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FIGURE LEGENDS 
Figure 1. Horizontal gene transfer process. Summary of the steps through which 
DNA is transported from donor to recipient bacteria, starting from a potential DNA 
in donor cell becoming available for transfer and ending with a stable integration 
into a recipient’s genome. This figure was reproduced by Thomas and Nielsen, 
2005 [4]. ................................................................................................................ 20 
Figure 2. Mechanisms of HGT transfer. a. In transformation, the naked DNA 
released lysed bacteria can be taken up by another one. Then, the antibiotic-
resistance genes can be incorporated to the recipient’s chromosome. b. In 
transduction, bacteriophages transfer antibiotic-resistance genes from one 
bacterium to another and those can be integrated into the recipient’s chromosome. 
c. Conjugation occurs by a direct contact between two bacteria, DNA is transferred 
to the recipient cells. This figure was reproduced by Furuya and Lowy, 2006  [22]
 .............................................................................................................................. 21 
Figure 3. Life cycle of an integrative and conjugative element (ICE). An ICE can be 
integrated into the host chromosome at specific sites: the right (attR), and left (attL) 
ends. Excision of ICE by recombination between attL and attR to yield attP (in the 
ICE) and attB (in the host chromosome) can produce a circular molecule. During 
conjugation, the donor and potential recipient (ICE-free) establish a close contact, 
and a single DNA strand is transferred into the recipient through a rolling circle 
replication. Then, complementary strand is synthesized by DNA polymerase in the 
recipient regenerate the double-stranded in circular form. Finally, the ICE can be 
integrated into the host genome by a recombination event between attP and attB. 
This figure was reproduced by Wozniak  and Waldor., 2010  [40]. ....................... 24 
Figure 4. Junctions between E. coli strain during RP4-mediated conjugation on 
filter. (A) Mating cell aggregates at lower magnification. Arrows indicate junctions; 
s indicates septum. Bar, 0.5 μm. (B) Pairs of bacteria established conjugation 
junction (arrows). Bar, 0.25 μm. (C) Junction at high magnification showed a 
electron-dense area between outer membranes (arrow), lightly staining outer 
membrane (OM), dense periplasmic gel (P), and lightly staining inner cytoplasmic 
membrane (CM). Bar, 100 nm This figure was reproduced by Samuels et al., 2000 
[45]. ....................................................................................................................... 27 
Figure 5. Type IV secretion system (T4SS) functioning modes.  (A) In the 
biogenesis mode, the pilus is grown from a structure within the T4SS and at this 
point VirB11 (light brown) interacts with VirB4 (green) to activate this mode. (B) In 
the substrate translocation mode, VirB11 (light brown) interacts with VirD4 (purple) 
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(AP); origin of transfer (oriT) DNA; and integration host factor (IHF)] processes the 
DNA and is recruited to the T4SS by the VirD4 coupling protein (CP; left panel). 
The DNA and relaxase are then transferred to the recipient cell (right panel). This 
figure was reproduced by Ilangovan et al., 2015 [48]. ........................................... 28 
Figure 6. Visualization of PAPI-1-encoded pili under transmission electron 
microscopy (TEM). (A) The immunogold labelling is specific to the Flag tag, since 
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(PA14TnC2 ΔpilS2ΔpilA ppilS2). (B) gold-labelled PAPI-1 pili (arrow with open 
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(filled arrow) are well visualized. This figure was reproduced by Carter et al., 2010  
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Figure 7.  Genomic location of PAPI-1 (A) and PAPI-2 (B) in PA14 compared to 
PAO1 strain.  Above and below the lines represent gene designations and length 
(bp), respectively. The left-boundary and right-boundary conserved regions are 
highlighted with light and dark gray shading represent, respectively.  This figure 
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Figure 8. Genomic organization of PAPI-1 (A) and PAPI-2 (B). The individual 
ORFs and their transcriptional orientations are described by the boxes with arrows. 
Empty boxes indicate pseudogenes; triangles indicate tRNA genes; and the 
vertical black line indicates the attR “attachment” site. The numbered lines indicate 
size (kb).  The direct repeats (DR1–5), inverted repeat (IR), and insertion 
sequences are marked by the coincident rectangles and single or double-headed 
arrows on the line, respectively. The color and pattern of ORF represent the 
putative protein function and the bacterial species it is most related to, respectively 
according to the key. Virulence-related ORFs are represented in red shading. 
Functions of gene clusters are correspondingly presented to the ORFs above the 
notations. The yellow shaded regions present the homology between PAPI-1 and 
PAPI-2. This figure was reproduced by He et al., 2004  [89]. ................................ 38 
Figure 9. Structure of the gram-negative bacterial cell envelope. OM, Outer 
membrane containing glycerophospholipids in the inner leaflet, mosaicked with 
porins as the major protein components and LPS structure in the outer leaflet, 
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(PG); IM, inner membrane This figure was reproduced by Tommassen et al., 2010  
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Figure 10. Heterogeneity of the LPS glycoforms on the surface of P. aeruginosa 
[107]. In P. aeruginosa, there are two types of O-antigen characterized. A-band 
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ABSTRACT 
Horizontal gene transfer (HGT) allows rapid exchanges of large genetic elements 
and is known to play an important role in bacterial evolution and adaptation. 
Conjugative transfer of genomic islands (GIs) has recently been reported in the 
opportunistic pathogen Pseudomonas aeruginosa. PAPI-1, one of the largest 
pathogenicity islands of P. aeruginosa, encodes several putative virulence genes 
and a major regulator of biofilm formation and antibiotic-resistant traits and was 
found to be horizontally transferable into strains lacking it. The conjugation of 
PAPI-1 island transfer is mediated by type IV pilus, which is encoded by ten genes 
located in PAPI-1. Nevertheless, the acquisition mechanism of PAPI-1 is currently 
not well understood.  
The first part of this thesis was aimed at identifying the receptor for conjugative 
transfer on the bacterial cell surface. Based on previous knowledge on bacterial 
conjugation, we designed and performed a series of mating experiments and 
analyzed transfer efficiency between PAPI-1 donor and recipient strains. Our data 
showed that A-band lipopolysaccharide (LPS) is required to initiate PAPI-1 
transfer, supporting the idea that this structure acts as a receptor for conjugative 
type IV pilus in recipient strains. These results were verified by PAPI-1 transfer 
inhibition experiments with outer membrane (OM) or LPS preparations. The 
addition of a low amount of OM or LPS derived from strains producing A-band 
decreased PAPI-1 transfer efficiency by 80% compared to controls. 
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In the second part, we demonstrated that P. aeruginosa strains which already 
acquired a copy of PAPI-1 almost completely lost the ability to receive additional 
copies of the island. Combination of strains with or without PAPI-1 were mated in-
pair to investigate the redundancy in PAPI-1 transfer. The surface exclusion of 
PAPI-1 was characterized by investigating the effects of the addition of OM and 
LPS derived from strains with or without PAPI-1. In addition, LPS of the different 
strains were analyzed by western blot using antibodies directed against different 
parts of the molecule and by testing the in-vitro binding capacity of LPS to pilin 
protein. All experiments indicated that the strains carrying PAPI-1 produced much 
less A-band LPS compared to those lacking the island and lost the ability to bind to 
conjugative pilin.  Finally, the screening of a series of mutants highlighted a role for 
two PAPI-1 genes in an entry exclusion activity, possibly through PAPI-1 island 
destabilization. 
This study contributes with a step forward in the understanding of the acquisition of 
genomic islands in P. aeruginosa, which may be generalized to other gram-
negative bacteria and may lead to the future development of new strategies to limit 
the spread of virulence or resistance functions in populations of pathogenic 
bacteria.    
Keywords: Pseudomonas aeruginosa, PAPI-1 pathogenicity island, horizontal 
gene transfer. 
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1. INTRODUCTION 
1.1.  Horizontal Gene Transfer (HGT) and bacterial evolution 
Horizontal gene transfer (HGT), also termed lateral gene transfer (LGT), refers to 
the transfer of clusters of genes between organisms, in contrast to vertical transfer, 
the transmission of genes from the parental generation to their offspring. HGT has 
been shown to play an important role in bacterial evolution, adaptation and spread 
of antibiotic resistance or virulence. 
1.1.1. Roles of HGT in bacterial evolution 
Bacterial evolution is known to be driven by alterations of genome sequence and 
structure. Together with mutations created during DNA replication and reparation, 
HGT plays a major role in large-scale, rapid evolution, since hundreds of new 
genes can be acquired with a single genetic exchange event [1], [2]. HGT may 
result in a better adaptation of the recipient cell to new environments with 
advantageous functions encoded by the transferred genes. The first HGT event 
was reported in Streptococcus pneumoniae when virulence factors were observed 
to be transferred among them through transformation mechanism, which further 
explained in the next part 1.1.2 [3]. Later, a number of gene transfer processes 
mediated by mobile genetic elements (MGEs) including plasmids and viruses were 
subsequently described in bacteria [4]. Computational analysis has also revealed 
that a considerable proportion of most bacterial genomes consist of horizontally-
acquired genes [4]. Therefore, genome analysis and comparisons suggested that 
HGT plays a key role in bacterial evolution and adaptation by sharing essential 
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metabolic functions, antibiotic resistances that might be beneficial under certain 
environmental conditions [5],[6],[7]. 
 
Acquisition of virulence or resistance genes may drastically alter the disease-
causing potential or antibiotic resistance of a microorganism. In some instances, 
acquisition of a single gene or a small cluster of genes encoding critical virulence 
determinants was found to be the only genetic difference between an avirulent and 
virulent strain of the same species [8], [9]. Virulence genes are often organized in 
large blocks of DNA, also called genomic islands (GIs). GIs, accessory genomic 
regions, are present only in certain bacterial strains which are often flanked by 
direct repeats, inserted in the vicinity of tRNA genes and eventually excised out 
[10]. Those GIs enhancing the fitness in a host organism are named pathogenicity 
islands [6]. Horizontal gene transfer (HGT) spreading resistance against a wide 
range of antimicrobials has resulted in a worldwide impact of nosocomial and 
community infections caused by multidrug-resistant microorganisms, such as 
Pseudomonas aeruginosa or Staphylococus aureus [11], [12]. The figure 1 
summarized the steps through which DNA must pass from donor to recipient. 
1.1.2.  Mechanisms of HGT in bacteria 
Bacteria can implement HGT through three main mechanisms: uptaking free DNA 
(transformation) or encapsulated DNA (transduction), or cell-to-cell contact 
(conjugation) (Figure 2). Transformation is a common mode in which naked DNA, 
usually short fragments, is naturally uptaken by competent bacteria. Transduction 
is the transfer of DNA from one bacterium to another via bacteriophages. 
17 
 
Conjugation is the direct transfer of plasmids or other types of mobile genetic 
elements between two bacterial cells, requiring cell-to-cell contact via type IV pilus. 
1.1.2.1. Transduction 
Transduction is a process in which phages can pick up bacterial genes and carry 
them from one bacterial cell to another. Transduction was first described in studies 
on gene exchange between Salmonella bacteria [13]. There are two types of 
phage cycle: virulent phages immediately undergo their replicative cycle, lysing the 
host; temperate phages can remain integrated in the host cell genome for a period 
without killing it. A phage integrated into the bacterial genome is called a prophage 
and a bacterium harboring a quiescent phage is called lysogenic. There are two 
kinds of transduction: generalized and specialized. In the generalized transduction, 
phages can carry any fragment of the bacterial chromosome, whereas specialized 
transducing ones can pick up only certain specific parts. These strategies were 
identified to contribute to this horizontal transfer of genes between different host 
bacteria [14] . 
Generalized transduction 
Generalized transduction is a process in which any gene can be transferred from 
one bacterium to another by phages. The process includes two steps: the 
packaging of donor DNA into a phage particle and the stable introduction of this 
packaged DNA into the recipient cell, usually through genetic recombination with 
the recipient chromosome. The ability of a phage to perform generalized 
transduction thus depends on the mechanism of packaging DNA into phage 
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particles. There are numerous types of DNA metabolism that lead to generalized 
transduction. In each case, the capability for generalized transduction is a result of 
the mode of packaging phage DNA. 
Specialized transduction 
In this mode, the transduced genes can be covalently joined to the viral 
chromosome, then replicated, packaged, and introduced into a recipient with the 
rest of the viral chromosome. Besides, a specialized phage carries a specific 
chromosome segment, and consistently introduces it into the recipient [15]. 
The temperate phage  is a classic example of this kind. This phage contains a 
linear double-stranded DNA molecule with complementary 12 nucleotide single-
stranded ends [16]. When infecting to a cell, these ends are hybridized (cos sites); 
therefore, its chromosome is circularized, and the phage then chooses between 
two alternative life cycles. In the lytic cycle, the chromosome replicates to form 
concatemers to be packaged into particles with a limit of size about 35,000 bp to 
50,000 bp. In this case, the phage DNA is integrated into the bacteria chromosome 
and a repressor for the lytic gene products is produced. Then, it is replicated and 
passively carried by the bacterium as a latent prophage. The integration occurs by 
breaking the phage chromosome at a specific site, attP, and joins it to the host at 
another specific one, attB [17]. When the prophage is induced, the phage 
repressor is inactivated and the reverse reaction occurs.  
Phages contribute an extremely high impact on the bacterial evolution since the 
global rate of phage-mediated genetic modification in bacteria has been estimated 
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up to ~2×1016 events per second [18]. Phages are also indirectly responsible for 
horizontal gene transfer (HGT) by transformation. By inducing bacterial lysis, 
released bacterial DNA can then be acquired by neighboring competent cells. 
Many phage-mediated HGT occurs by generalized transduction mechanism, 
where bacterial DNA is accidentally packaged and delivered into neighboring cells 
[19]. Moreover, transduction can also facilitate the mobilization of antibiotic 
resistance and virulence genes [20] [21]. 
20 
 
 
 
Figure 1. Horizontal gene transfer process. Summary of the steps through which DNA 
is transported from donor to recipient bacteria, starting from a potential DNA in donor cell 
becoming available for transfer and ending with a stable integration into a recipient’s 
genome. This figure was reproduced by Thomas and Nielsen, 2005 [4].  
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Figure 2. Mechanisms of HGT transfer. a. In transformation, the naked DNA released 
lysed bacteria can be taken up by another one. Then, the antibiotic-resistance genes can 
be incorporated to the recipient’s chromosome. b. In transduction, bacteriophages transfer 
antibiotic-resistance genes from one bacterium to another and those can be integrated 
into the recipient’s chromosome. c. Conjugation occurs by a direct contact between two 
bacteria, DNA is transferred to the recipient cells. This figure was reproduced by Furuya 
and Lowy, 2006  [22]. 
 
22 
 
1.1.2.2. Natural Transformation  
Natural transformation is the uptake of free DNA from the extracellular 
environment by bacteria, usually via a pore-like structure in the bacterial cell 
membrane [23]. This property is widely found among prokaryotes (including 
Archaea), inferring that natural competence has a long evolutionary history [24]. To 
initiate natural transformation, bacterial cells must first reach a regulated 
physiological state involving approximately 20 to 50 proteins. Remarkably, the 
proportion of bacteria that can develop competence ranges from near zero to 
almost 100% of the bacterial population [4]. The natural transformation has been 
detected in Archaea and different bacterial phyla, including Gram-positive bacteria 
and Cyanobacteria [24]. Importantly, many human pathogenic bacterial genera 
such as Campylobacter, Haemophilus, Helicobacter, Neisseria, Pseudomonas, 
Staphylococcus and Streptococcus are also naturally competent [24].  Natural 
transformation only occurs when there are free extracellular DNA, the presence of 
competent bacterial cells and the ability to stabilize the acquired DNA by 
integration into the bacterial genome or self-replicated in the recipient cells. 
1.1.2.3. Conjugation 
Conjugation is another HGT mechanism first described by Lederberg J and Tatum 
EL, 1953 [25] as bacterial sexual reproduction. Among different HGT mechanisms, 
conjugation has the most complex requirements. Known conjugative elements 
include plasmids, MGEs, or integrative and conjugative elements (ICEs) which are 
self-transmissible MGEs [26]. Plasmids or MGEs are generally transmitted by 
conjugation since they are usually too large to be transferred by transduction or 
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natural transformation [27], [28]. The schematic of the ICE transfer is well 
presented in the figure 3. 
With conjugative apparatuses, large genetic elements, including chromosomes can 
be easily transmitted, providing a dynamic manner of bacterial evolution. 
Conjugation allows a rapid and efficient gene transfer in bacteria, mediated by 
factors which are usually encoded in plasmid or ICEs. Mating among E. coli cells 
mediated by IncF and IncI plasmids occurs in several steps: (i) pilus-to-wall contact 
formation, (ii) wall-to-wall contact, (iii) stabilization of the contacts, (iv) DNA 
transmission and (v) active disaggregation of the mating complexes [29], [30], [31], 
[32].  Remarkably, many studies, especially in gram-positive bacteria, suggested 
that before establishing stable mating pairs, the donors can recognize the 
recipients through signaling molecules such as pheromones [33], [34], [35]. [36, 
37] or small peptides [38]. Recently, it has also been found in gram-negative 
bacteria that 3-oxo-C6- homoserine lactone (3-oxo-C6-HSL) which is a quorum 
sensing signal was able to control the gene transfer [39].  
When the donors and recipients get closer and establish a physical contact 
sufficiently stable to allow transfer of DNA (Figure 4). During the transfer, 
metabolism of both cells has to be simultaneously active to allow DNA synthesis 
and other activities [24]. The cell-to-cell junctions allow DNA to pass, although the 
natures of these structures are not fully understood. The donor can contact 
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Figure 3. Life cycle of an integrative and conjugative element (ICE). An ICE can be 
integrated into the host chromosome at specific sites: the right (attR), and left (attL) ends. 
Excision of ICE by recombination between attL and attR to yield attP (in the ICE) 
and attB (in the host chromosome) can produce a circular molecule. During conjugation, 
the donor and potential recipient (ICE-free) establish a close contact, and a single DNA 
strand is transferred into the recipient through a rolling circle replication. Then, 
complementary strand is synthesized by DNA polymerase in the recipient regenerate the 
double-stranded in circular form. Finally, the ICE can be integrated into the host genome 
by a recombination event between attP and attB. This figure was reproduced by Wozniak  
and Waldor., 2010  [40]. 
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recipients through a connecting tube (pilus) or in some cases through a pore  [41]. 
S. aureus, a gram-positive bacterium, utilize transferring pores encoded by tra 
genes instead of pilus formation to allow DNA transfer [42].  
In many cases, the donors bearing plasmids have been shown the ability to target 
different recipients through the specificity of the interaction between their pilus and 
LPS and/or outer membrane proteins on the recipient cell surface [43], [44]. For 
examples, the IncP and Ti plasmids, some mating-pair formation apparatuses can 
form productive junctions with different cell-type surfaces [45], [46], including not 
only gram-negative bacteria but also gram-positive bacteria, yeast, plant and 
animal cells.. However, the plasmid transfer efficiency among the same strains or 
different strains can be different. For instance, transfer efficiency of IncP-1 
plasmids between E. coli strains or from E. coli to Pseudomonas putida is slower 
than transfer between P. putida strains [47]. 
In many gram-negative bacteria, type IV secretion systems (T4SSs) has been 
known to be responsible for conjugative transfer [48]. T4SS, one of six major 
classes of secretion system, is a large structure connecting both the inner and 
outer membranes of bacteria. Initially, the origin of transfer of plasmid (oriT) is 
processed in the cytoplasm leading to the formation of a multiprotein-DNA 
complex, so-called the relaxosome. The relaxosome contains relaxase enzyme as 
a crucial component and various accessory proteins which may be necessary for 
efficient recognition of oriT [49]. Subsequently, a coupling protein (T4CP) brings 
this complex to a T4SS and translocates the DNA from the donor to the recipient 
cell. Two types of T4SS pilus have been described, a long and flexible F-type 
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pilus, and a short and rigid P-type pilus [50]. Pilus contains a lumen, which is 
approximately 30A˚ in diameter, allowing passage of single-stranded DNA [51]. 
The conjugative pilus structure of A. tumefaciens was the most studied including 
the major and minor pilin proteins VirB2 and VirB5. It is known that the pilin 
proteins VirB2 of A. tumefaciens and TrbC encoded by the RP4 plasmid are post-
translationally modified by cleaving the signal peptide followed by fusion of the N- 
and C-terminal ends to cyclize the peptide [52], [53], and then acetylated before 
being inserted into the inner membrane of the bacterium [54]. The T4SS possibly 
functions in two modes associated structural conformations, including pilus 
biogenesis and substrate transfer modes (Figure 5) [55].  
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Figure 4. Junctions between E. coli strain during RP4-mediated conjugation on 
filter. (A) Mating cell aggregates at lower magnification. Arrows indicate junctions; s 
indicates septum. Bar, 0.5 μm. (B) Pairs of bacteria established conjugation junction 
(arrows). Bar, 0.25 μm. (C) Junction at high magnification showed a electron-dense area 
between outer membranes (arrow), lightly staining outer membrane (OM), dense 
periplasmic gel (P), and lightly staining inner cytoplasmic membrane (CM). Bar, 100 nm 
This figure was reproduced by Samuels et al., 2000 [45]. 
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Figure 5. Type IV secretion system (T4SS) functioning modes.  (A) In the biogenesis 
mode, the pilus is grown from a structure within the T4SS and at this point VirB11 (light 
brown) interacts with VirB4 (green) to activate this mode. (B) In the substrate translocation 
mode, VirB11 (light brown) interacts with VirD4 (purple) to assist the substrate transfer. 
The relaxosome [relaxase (R); accessory protein (AP); origin of transfer (oriT) DNA; and 
integration host factor (IHF)] processes the DNA and is recruited to the T4SS by the VirD4 
coupling protein (CP; left panel). The DNA and relaxase are then transferred to the 
recipient cell (right panel). This figure was reproduced by Ilangovan et al., 2015 [48]. 
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1.1.3. HGT exclusion activity in bacteria 
Back to the early history of conjugation, it has been known that recipients after 
they already acquired a plasmid can activate a exclusion system to avoid entry of 
another copy. This is usually a property of plasmids, encoded by at least one gene 
and essential for their stability. It has also been suggested that exclusion 
mechanism limits the damage of lethal zygosis in which bacterial death is induced 
by excessive rounds of conjugation. In addition, it may also avoid competition 
among identical plasmid backbones in a host. On the other hand, it could be 
understood that the lack of exclusion mechanism may generate a rapid 
evolutionary change [56].  There are at least two existing exclusion for the entry of 
plasmid or ICEs identified among bacteria : surface exclusion and entry exclusion. 
1.1.3.1. Surface exclusion 
This mechanism was originally described for the transfer of F plasmid in E. coli. 
The surface exclusion creates an effective barrier against conjugative transfer into 
bacterial cells already carrying specific genetic elements [57]. Surface exclusion 
has been found in conjugation systems of both gram-negative [52], [58] and gram-
positive bacteria [59]. TraT is an outer membrane lipoprotein which can disturb the 
interaction between the pilus tip and OmpA receptor in E.coli [60]. In F plasmid, 
protein TraT changes the outer surface of the cell and reduces its binding capacity 
to the F pilus about 10-fold,. However, a large number of inter-plasmid 
recombination events were found among different F-like plasmids or IncP-1 
plasmids [61].This indicates that despite surface exclusion, plasmids can still enter 
cells that carry a closely related element. In F plasmid transfer, the surface 
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exclusion activity is decreased in stationary phase in liquid culture, in non-growing 
populations on agar plates and under starvation of carbon source [62]. Studies on 
F plasmids revealed that surface exclusion might be relevant to the disruption of 
mating pairs after gene transfer and for release of the recipient [63].  
1.1.3.2.  Entry exclusion 
Entry exclusion includes a wide-range of mechanisms inhibiting DNA entry after a 
mating pair established [30], [32]. For F plasmid, the entry exclusion showed a 
stronger barrier for gene transfer than surface exclusion mechanism, in which 
protein TraS, located in the inner membrane, prevents DNA entry by about 100-
fold. An Eex system of the IncP plasmid RP4, including a single inner membrane 
lipoprotein (TrbK), further blocks acquisition of closely related plasmids by 
interacting and interfering with one or several proteins responsible for mating pair 
formation [52]. F plasmids utilize a similar mechanism where the lipoprotein TraS 
in the recipient cells blocks entry of the second copy of the F-plasmid by 
interacting with the TraG protein of the donor [64], [65]. An analogue exclusion 
system, consisting of two proteins, Eex and TraG, regulates entry exclusion of 
Vibrio cholerae ICE SXT [66]. A significant number of plasmids and ICEs that 
control entry exclusion mechanisms lack obvious homologues of the plasmid 
exclusion systems, but they could utilize analogues Eex systems that have 
significantly diverged in their primary sequence from their plasmid ancestors [56].  
The entry of DNA can also lead to degradation by intracellular restriction 
endonucleases [67]. This exclusion activity depends on the plasmid size, and on 
whether it is single-stranded or double-stranded. Smaller plasmids contain fewer 
31 
 
restriction sequences and therefore are more likely to be protected from enzymatic 
cleavage [68]. 
The broad-host-range IncP-1 plasmid seems to have adapted to such barriers by 
losing most of its restriction sites [69]. Indeed, introduction of extra restriction sites 
into the plasmid increases the exclusion activity, resulting in a reduction of transfer 
efficiency [69], [70]. 
Besides, another barrier is to control plasmid replication and establishment in a 
heterologous host.  This mechanism allows a plasmid having no orthologue in the 
recipient genome to self-replicate without the need for recombination into the 
chromosome. This could be explained by replication proteins encoded in the 
plasmid. The broad-host-range plasmids, like RSF1010 belonging to the IncQ 
plasmids, contain three replication proteins — an origin activation protein, RepA; a 
helicase, RepB; and aprimase, RepC. In contrast, studies on narrow-host-range 
plasmids showed various limitations to successful replication. The replication of 
plasmid F of E. coli in Pseudomonas species seems to be restricted due to the 
inability of its replication protein, RepE, to effectively recruit DnaB to complete the 
activation of the replication origin [71].  
1.2. Pseudomonas aeruginosa  
Pseudomonas aeruginosa is a gram-negative bacteria found in a wide range of 
enviroments, including soil, water, plants, and animals [72], [73]. It was first 
described in 1882 by Carle Gessard, a French chemist and bacteriologist, 
elucidating a mystery of more than 20 years about a blue-green pigment observed 
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in patients during the pre-antiseptic era of surgery. It was later found to be 
responsible for a broad range of infections, including endocarditis, corneal keratitis, 
meningitis and systemic infections of children [74], [75], [76]. Recently, it was 
reported that P. aeruginosa causes 8% of nosocomial infections and cost for 
nosocomial pathogen treatment in America was between $28.4 and $45 billion and 
cause an estimated 1.7 million infections and 99,000 deaths each year [77], [78]. 
In addition, P. aeruginosa is well-known as the main cause of morbidity and 
mortality in patients suffering cystic fibrosis (CF) [79] which is the most common 
autosomal recessive genetic disorder among Caucasians, with a high frequency of 
about 1 in 2,500 live births [80]. 
P. aeruginosa infections are often associated with compromised host defenses 
such as severe burns, urinary tract infections, AIDS [81] lung cancer, chronic 
obstructive pulmonary disease, and CF [82]. Most CF patients get infected and 
chronically colonized with multi-drug resistant (MDR) P. aeruginosa, becoming 
nearly impossible to be eliminated despite aggressive antibiotic therapy [83]. P. 
aeruginosa has become one of the most common MDR bacteria isolated from 
ventilator-associated pneumonia [84]. 
The broad environmental distribution of P. aeruginosa is reflected by its large 
genomic repertoire beyond the core genome. Indeed, the genome sequences of P. 
aeruginosa strains available to date show that a large core genome of about 5000 
conserved genes is supplemented with an accessory gene pool of 1000-1500 
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additional genes, most of them being arranged in a limited number of genomic 
islands [85].  
1.2.1. Pathogenicity islands  
Integrative and conjugative elements (ICEs) are a large group of mobile genetic 
elements found in both gram-positive and gram-negative bacteria (Rachel, 2010), 
encoding various accessory activities such as symbiotic and pathogenesis 
functions. In many cases, ICEs have retained mobility [86, 87], while many others 
appear as ancient ICEs that became fixed in the bacterial chromosome due to 
degeneration of their conjugative elements [88]. The best-characterized ICEs to 
date contain specific features associated with conjugative plasmids and 
bacteriophages and are self-transmissible. ICEs, like all transmissible plasmids, 
are transferred following the recognition of the recipient cell by the donor utilizing a 
conjugative mechanism that, in many instances, is associated with the T4SS 
system [26]. 
In P. aeruginosa, two pathogenicity islands PAPI-1 (108 kb) and PAPI-2 (11 kb) 
has been recently identified and characterized as members of mobile ICE group 
[89]. It has been known that those islands can be integrated at into the 
chromosome at the attB site in the tRNALys gene PA4541.1 or PA0976.1 (Figure 
7). Importantly, they were found in a highly virulent clinical strain, PA14, while 
absent the less virulent reference strain PAO1 (Figure 8). Many of the genes within 
these islands are homologous to genes from other human or plant pathogens. 
PAPI-1 carries several regulatory genes, such as the PvrSR/RcsCB two 
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components system, which controls biofilm formation and dispersal in P. 
aeruginosa strains causing chronic infections in individuals with cystic fibrosis [90], 
[91]. Significantly, many PAPI-1 ORFs are also present in several P. aeruginosa 
cystic fibrosis isolates [89]. However, more than 80% of the PAPI-1 DNA sequence 
is unique to strain PA14, and about 70% of predicted ORF products exhibit no 
homology with any known proteins or functional domains. 19 PAPI ORFs were 
found to be necessary for full plant or animal virulence, with 11 required for both 
[89], [92].  
Conjugation has been known as the mechanism responsible for the transfer of 
PAPI-1 since this only occur when donor and recipient cells are co-cultured and 
not from a donor bacterium-free culture medium [93]. As mentioned above, a pilus 
is required to set-up mating pairs between donor and recipient cells. In PAPI-1, a 
10-gene cluster encoding type IV pilus closely related to the homologous genes in 
the conjugative plasmid R64, was identified. However, only nine of PAPI-1 Pil 
proteins showed high similarities to those encoded in plasmid R64, as components 
of the type IV pilus system (PilL2, -N2, -O2, -P2, -Q2, -R2, -S2, -T2, -V2, and -M2). 
The PilS2 and PilV2 are homologous to the major and minor subunits of R64 thin 
pilus, PilS and PilV. Computational analyses predicted that the function of pilN2, 
PilO2, PilP2, PilQ2, pilR2, PilM2, are type IV lipoprotein, type IV pilus secretin 
protein,  a pilus accessory protein, a pilus assembly protein, a pilus retraction 
ATPase, an integral membrane protein and an inner membrane protein, 
respectively [93].  
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Interestingly, the 10 PAPI-1 encoded pilus proteins are well conserved in several 
P. aeruginosa strains that carry this island, including PA2192, C3710, PACS2, 
PA7, and PSE9 (PAGI-5), and in P. aeruginosa clone C strain that carry a 
pKLC102-like element [78], [85], [94]. The PAPI-1 pilS2 gene encodes for a major 
pilin subunit, which is a 176-amino-acid protein containing a conserved PilS 
superfamily domain. However, the PAPI-1 encoded conjugation system in P. 
aeruginosa is incomplete since it lacks prepillin peptidase, which is responsible for 
the cleavage of the PilS2 leader peptide and is located in the core genome. The 
PAPI-1 encoded pili was previously visualized under transmission electron 
microscopy (TEM) (Figure 6). 
In plasmid-based conjugative transfer in E. coli, the F pilus is required for initiating 
the cell-to-cell contact and forming mating pairs during the conjugation process. 
R64 plasmid transfer is one of these well-studied systems. Plasmid R64 encodes 
type IV pilus with the PilV adhesins located at its tip [95], [96]. The C-terminal 
segments of the PilV adhesins are exchanged by multiple DNA inversions of the 
shufflon containing seven recombination sites, which flank and separate four DNA 
segments [97, 98] in order to determine the recipient specificity in R64 liquid 
matings [99, 100]. It was demonstrated that each adhesin can recognize a specific 
structure of LPS molecules of recipient cells [101]. 
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Figure 6. Visualization of PAPI-1-encoded pili under transmission electron 
microscopy (TEM). (A) The immunogold labelling is specific to the Flag tag, since there is 
little labelling of the native pili of the control cells without Flag-tagged PilS2 (PA14TnC2 
ΔpilS2ΔpilA ppilS2). (B) gold-labelled PAPI-1 pili (arrow with open head) of Flag-tagged 
cells (PA14TnC2 ΔpilS2ΔpilA ppilS2-flag) next to the flagella (filled arrow) are well 
visualized. This figure was reproduced by Carter et al., 2010  [93]. 
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Figure 7.  Genomic location of PAPI-1 (A) and PAPI-2 (B) in PA14 compared to PAO1 
strain.  Above and below the lines represent gene designations and length (bp), respectively. 
The left-boundary and right-boundary conserved regions are highlighted with light and dark gray 
shading represent, respectively.  This figure was reproduced by He et al., 2004  [89]. 
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Figure 8. Genomic organization of PAPI-1 (A) and PAPI-2 (B). The individual ORFs 
and their transcriptional orientations are described by the boxes with arrows. Empty boxes 
indicate pseudogenes; triangles indicate tRNA genes; and the vertical black line indicates 
the attR “attachment” site. The numbered lines indicate size (kb).  The direct repeats 
(DR1–5), inverted repeat (IR), and insertion sequences are marked by the coincident 
rectangles and single or double-headed arrows on the line, respectively. The color and 
pattern of ORF represent the putative protein function and the bacterial species it is most 
related to, respectively according to the key. Virulence-related ORFs are represented in 
red shading. Functions of gene clusters are correspondingly presented to the ORFs above 
the notations. The yellow shaded regions present the homology between PAPI-1 and 
PAPI-2. This figure was reproduced by He et al., 2004  [89]. 
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1.2.3. Outer membrane and LPS structure  
The cell envelope of Gram-negative bacteria consists of two membranes, the 
cytoplasmic membrane and the outer membrane, with periplasm containing 
peptidoglycan cell wall in between. The cytoplasmic membrane is a phospholipid 
bilayer constituted of glycerophospholipids mosaicked with proteins. The outer 
membrane is asymmetrical, containing glycerophospholipids in the inner leaflet, 
and lipopolysaccharides (LPSs) exposed to the cell surface, as well as integral 
outer-membrane proteins (OMPs) (Figure 9) [102]. The outer membrane protects 
the bacteria from harmful substances in the environment, such as antibiotics and 
bile salts, while it allows most nutrients to pass via a family of integral OMPs, so-
called porins. Other OMPs are specified for transport functions, such as the 
secretion of proteins, or function as enzymes or structural composition of the outer 
membrane [103]. LPS is constituted of three parts: a proximal hydrophobic lipid A 
region, a core oligosaccharide region, and an O-antigen polysaccharide region. 
In Pseudomonas aeruginosa, at least six conserved major proteins were identified 
in the outer membrane, including D (50 kDa), E (45 kDa), F (33 kDa), G and H (21 
KDa), I (8 kDa) [104]. The cytoplasmic membrane consists of many protein 
species, and minimum fifty protein bands were detected by SDS-PAGE [104]. 
Pseudomonas aeruginosa shows a 10- to 100-fold lower outer membrane 
permeability, as compared to other gram-negative bacteria (e.g. E. coli). This 
unique feature slows down the trans-outer-membrane drug diffusion, aiding the 
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function of secondary resistance mechanisms (such as efflux systems and 
enzymatic modification or degradation). The main factor for P. aeruginosa outer 
membrane permeability to antibiotics is the major porin OprF [104], and possibly 
other porins, such as OprB and OprD. More than 160 genes/ORFs encoding 
putative outer membrane proteins are found in the P. aeruginosa genome, 
implicating a much more complex system than in other gram-negative bacteria 
[105]. 
Lipopolysaccharide is a complex glycolipid structure, which is the main component 
of the outer membrane of gram-negative bacteria. LPS has an important role in 
antigenicity, inflammatory response, exclusion of external molecules, and also 
antibiotic interaction [106]. While the inner core is constituted of two D- manno -2-
keto- octulosonic acid residues and two L- glycero -D- manno -heptose residues, 
the Lipid A moiety and the O-antigen are composed of various molecules. The lipid 
A contains diglucosamine biphosphate backbone with O- and N-linked primary and 
secondary fatty acids anchored to the LPS on the bacterial outer membrane. The 
lipid A structure differs in the number, the position, and the nature of acyl groups, 
as well as in the modification of the phosphate groups [107]. Lipid A is the domain 
of LPS that mediates inflammatory response-induced endotoxicity [108]. Many lipid 
A modifications are associated with environmental changes, including the 
presence of antibiotics or during CF infection [109], [110], [111].  
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Figure 9. Structure of the gram-negative bacterial cell envelope. OM, Outer 
membrane containing glycerophospholipids in the inner leaflet, mosaicked with porins 
as the major protein components and LPS structure in the outer leaflet, exposed to the cell 
surface; PP, periplasm containing the peptidoglycan layer (PG); IM, inner membrane This 
figure was reproduced by Tommassen et al., 2010  [102]. 
 
The figure 10 presented the diversity of the LPS glycoforms on the surface of P. 
aeruginosa. Two different types of O-antigen have been characterized: A-band 
LPS is a homopolymer of D-rhamnose which elicits a weak antibody response; B-
band LPS is a heteropolymer with three to five distinct sugars in its repeat units 
with a strong antibody response and is the chemical basis for serotyping [112]. 
Some isolates, lacking the O-antigen, have a “rough” colony morphology 
compared to the smooth isolates producing it, while others, identified as “semi-
rough”, substitute the lipid A and core with only one O-saccharide unit [113].  
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Figure 10. Heterogeneity of the LPS glycoforms on the surface of P. aeruginosa 
[107]. In P. aeruginosa, there are two types of O-antigen characterized. A-band LPS, or 
Common Polysaccharide Antigen, is a homopolymer of D-rhamnose with about 70 sugars 
long, elicits a weak antibody response. B-band LPS, or O-Specific Polysaccharide Antigen 
containing a heteropolymer of repeated units of three to five distinct sugars and 
constitutes the chemical basis for serotyping. B-band LPS is highly immunogenic and 
elicits a strong antibody response. This figure was reproduced by Knirel et al., 2006  [112].  
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2. AIMS OF THE PROJECT 
Horizontal gene transfer is known as a major evolutionary mechanism in 
prokaryotes and contributes to the virulence properties of many bacterial 
pathogens. Pseudomonas aeruginosa pathogenicity island 1 (PAPI-1) has 
previously been shown to be transferable from one strain to another through 
conjugation process mediated by type IV pilus. However, the detailed PAPI-1 
transfer mechanism, especially acquisition and exclusion abilities have not been 
elucidated to date. To achieve this goal, this thesis project will address two specific 
aims. 
 
First, we aim at demonstrating the existence of a physical contact between P. 
aeruginosa donors and recipients to initiate the PAPI-1 transfer. For this purpose 
we will perform a series of mating experiments and analyzed transfer efficiency 
between PA14TnC2 donor carrying PAPI-1 and PAO1 recipients. The results will 
show us which components of the recipient’s cell surface are involved in the 
transfer. Afterward, PAPI-1 transfer inhibition assays with the addition of OM or 
LPS derived from different strains will be carried out to verify the existence of a 
receptor on the recipient’s outer membrane. 
 
The second aim is to investigate the mechanism of PAPI-1 exclusion in P. 
aeruginosa strains that already acquired a copy of the island. For this purpose, we 
will test combinations of strains with or without PAPI-1 for in-pair mating to analyze 
the redundancy in PAPI-1 transfer. Experiments will consist in testing the effects of 
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OM and LPS derived from strains with or without the island, analyze LPS of the 
different strains by WB using antibodies directed against different parts of the 
molecule, and testing the in-vitro binding capacity of LPS to pilin protein. Last, a 
screening of mutants for PAPI-1 genes will be performed to identify any PAPI-1 
genes involved in the exclusion system. 
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3. MATERIALS AND METHODS 
3.1. Strains and plasmids 
All strains and plasmids used in this study are listed in Table 1, 2, 3, 4. P. 
aeruginosa strains and mutants were grown in Luria-Bertani (LB) broth (Sigma-
Aldrich) supplemented with the appropriate antibiotics. For selection of P. 
aeruginosa mutants, the antibiotics used were gentamicin and tetracycline, both at 
a concentration of 75 µg/ml. For maintenance of plasmids in E. coli, the medium 
was supplemented with ampicillin at 100 µg/ml and chloramphenicol at 34 µg/ml. 
Isopropyl-D-thiopyranoside (IPTG) was added at a final concentration of 0.1 mM to 
induce GST-pilV2’ expression in pGEX-2T plasmid. 
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Table 1. Strains and plasmids used in this study 
Strains or plasmids 
Antibiotic 
resistancea 
Description 
Source 
reference, or 
accession no. 
E. coli strains 
   
E. coli SM10 None 
Host strain for plasmids pEXG2, 
mini-CTX, and their derivatives 
Lory’s lab 
collection 
E. coli pir S17.1 None 
Transfer pEXG2 plasmid into P. 
aeruginosa by conjugation 
[113] 
P. aeruginosa strains 
  
PA14 None Burn isolate [91] 
PA14∆soj (PA14 -) GmR 
Deletion mutant of PAPI-1 soj in 
strain PA14, which does not carry 
PAPI-1 island 
[91] 
PA14∆TnC2::GmR 
(PA14+) 
GmR 
Strain PA14 with a transposon 
MAR2×T7 inserted at nucleotide 
1634 of PAPI-1 gene RL090 
(PA14_59200) 
[114] 
PA14∆TnC2::TcR 
(PA14+) 
TcR 
Partially deletion of the PA14_59200 
gene in strain PA14 by insertion of 
tetracycline resistant gene in the 
middle 
This study 
PAO1 (or PAO1 -) TcR 
PAO1 with Tet gene inserted at the 
CTX phage att site on the 
chromosome 
Lory’s lab 
collection 
PAO1Bla6 CbR 
PAO1 with genes bla and 
lacZ inserted at the CTX phage 
att site on the chromosome 
[91] 
PAO1Bla6TnC2::GmR 
(PAO1+) 
GmR   
CbR 
Transconjugant of the mating 
between PA14∆TnC2 (GmR) and 
PAO1Bla6 
This study 
PAO1Bla6TnC2::TcR 
(PAO1+) 
GmR  
CbR 
Transconjugant of the mating 
between PA14∆TnC2::TcR and 
PAO1Bla6 
This study 
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PAO1∆wzx GmR 
In-frame deletion of the wzx gene in 
strain PAO1, deficient in B-band 
LPS synthesis 
[114]Islam et al., 
2012 
Plasmids 
   
pEXG2 GmR 
Gene replacement vector for 
constructing deletion or insertion 
mutants of P. aeruginosa 
[115] 
pJET1.2 AmpR Plasmid used for DNA blunt cloning 
Thermo 
Scientific 
pGEX-2T AmpR Expression vector for GST-pilV2’ GE Healthcare 
mini-CTX2 TcR 
Gene delivery vector for inserting 
genes at the CTX phage att site on  
P. aeruginosa chromosome 
AF140579 
pFLP2 AmpR 
Plasmid used for resolving the 
backbone of mini-CTX 
[115] 
pEXG2 GmR 
Gene replacement vector for 
constructing deletion or insertion 
mutants of P. aeruginosa 
[115] 
pJET1.2 AmpR Plasmid used for DNA blunt cloning 
Thermo 
Scientific 
pGEX-2T AmpR Expression vector for GST-pilV2’ GE Healthcare 
 
↵a Ampr, ampicillin resistance; Gmr, gentamicin resistance; Cbr, carbenicillin resistance; 
Tcr, tetracycline resistance. 
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Table 2. List of PAO1 mutants for lipopolysaccharide biosynthesis used in 
the screening 3.2 
Number 
PA 
ORF 
Gene 
Abbrev. 
Putative ORF Function 
Position in PAO1 
transposon 
mutant library 
(source: [115]) 
1 PA0705 migA alpha-1,6-rhamnosyltransferase MigA phoAwp01q4A03 
2 PA0936 lpxO2 lipopolysaccharide biosynthetic protein LpxO2 lacZwp03q3H09 
3 PA3141 wbpM nucleotide sugar epimerase/dehydratase  (*) 
4 PA3157   probable acetyltransferase phoAwp08q3G06 
5 PA3160 wzz O-antigen chain length regulator phoAbp02q3G06 
6 PA3193 glk Glucokinase phoAwp07q4C11 
7 PA3337 rfaD ADP-L-glycero-D-mannoheptose 6-epimerase phoAwp05q3A01 
8 PA3552 arnB ArnB phoAwp08q4G12 
9 PA3554 arnA ArnA lacZwp07q3F04 
10 PA3555 arnD ArnD phoAwp04q2C06 
11 PA3556 arnT inner membrane L-Ara4N transferase ArnT lacZwp07q1F11 
12 PA4458   conserved hypothetical protein phoAwp07q2G01 
13 PA4512 lpxO1 lipopolysaccharide biosynthetic protein LpxO1 phoAwp07q3E07 
14 PA4661 pagL Lipid A 3-O-deacylase phoAbp02q4E08 
15 PA5001   hypothetical protein phoAwp01q3H11 
16 PA5002   hypothetical protein lacZbp03q3E06 
17 PA5005   probable carbamoyl transferase phoAwp09q3B06 
18 PA5009 waaP lipopolysaccharide kinase WaaP phoAwp05q4G09 
19 PA5011 waaC heptosyltransferase I lacZwp04q4G06 
20 PA5012 waaF heptosyltransferase II lacZwp08q1C03 
21 PA5447 wbpZ glycosyltransferase WbpZ lacZwp02q1H10 
22 PA5448 wbpY glycosyltransferase WbpY phoAwp02q1F12 
23 PA5449 wbpX glycosyltransferase WbpX lacZwp01q4A02 
24 PA5450 wzt ABC subunit of A-band LPS efflux transporter phoAwp10q1E09 
25 PA5452 wbpW 
phosphomannose isomerase/GDP-mannose 
WbpW lacZwp08q4H11 
26 PA5453 gmd GDP-mannose 4,6-dehydratase lacZwp02q3E02 
27 PA5454 rmd oxidoreductase Rmd lacZwp01q1B08 
28 PA5455   hypothetical protein phoAwp08q4H06 
29 PA5456   hypothetical protein lacZwp02q4C05 
30 PA5457   hypothetical protein lacZwp06q1F08 
31 PA5458   hypothetical protein phoAwp10q1C10 
32 PA5459   hypothetical protein phoAwp08q1B12 
33 PA5322 algC phosphomannomutase phoAwp07q4D07 
 
 (*): Lory’s lab collection 
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Table 3. List of PA14 mutants for PAPI-1 genes used in the screening 3.11 
 
Number PA ORF 
Gene 
Abbrev. 
Size(bp) Gene function 
Position in PA14 
transposon mutant 
library (Source: [116]) 
1 PA14_60190 clpB 318 Hypothetical protein  PAMr_nr_mas_03_4:G11 
2 PA14_60140 xerC 1284 Integrase PAMr_nr_mas_11_2:F5 
3 PA14_60130 RL003 1920 Hypothetical protein  PAMr_nr_mas_08_2:B6 
4 PA14_60110 RL005 711 Hypothetical protein  PAMr_nr_mas_03_4:D3 
5 
PA14_60100 Dtd 540 
Deoxycytidine 
triphosphate 
deaminase PAMr_nr_mas_12_4:C1 
6 PA14_60080 RL008 1932 Hypothetical protein  PAMr_nr_mas_10_3:E1 
7 PA14_60070 RL009 2424 Hypothetical protein  PAMr_nr_mas_12_4:H8 
8 PA14_60060 RL010 303 Hypothetical protein  PAMr_nr_mas_01_2:F9 
9 
PA14_60050 parE 351 
Plasmid stabilization 
protein parE  PAMr_nr_mas_15_2:C5 
10 PA14_60030 RL013 345 Hypothetical protein  PAMr_nr_mas_09_3:E5 
11 PA14_60020 RL014 1512 Hypothetical protein  PAMr_nr_mas_06_4:D11 
12 PA14_60010 RL015 342 Hypothetical protein  PAMr_nr_mas_13_3:D8 
13 PA14_60000 RL016 1383 Hypothetical protein  PAMr_nr_mas_08_3:G8 
14 PA14_59990 RL017 939 Hypothetical protein PAMr_nr_mas_07_3:F5 
15 PA14_59980 RL018 432 Hypothetical protein PAMr_nr_mas_07_4:B10 
16 PA14_59970 RL019 219 Hypothetical protein  PAMr_nr_mas_10_2:A3 
17 
PA14_59960 dsbG 660 
Putative protein-
disulfide isomerase PAMr_nr_mas_10_2:D8 
18 PA14_59950 RL021 285 Hypothetical protein PAMr_nr_mas_10_3:B5 
19 PA14_59940 RL022 2943 Hypothetical protein PAMr_nr_mas_02_1:F1 
20 PA14_59920 RL024 1506 Hypothetical protein PAMr_nr_mas_09_1:G2 
21 PA14_59910 RL025 885 Hypothetical protein PAMr_nr_mas_07_3:F2 
22 PA14_59900 RL026 660 Hypothetical protein PAMr_nr_mas_03_4:F5 
23 PA14_59890 RL027 387 Hypothetical protein PAMr_nr_mas_10_1:D11 
24 PA14_59870 RL029 240 Hypothetical protein PAMr_nr_mas_13_2:H12 
25 PA14_59850 RL031 306 Hypothetical protein  PAMr_nr_mas_04_1:E12 
26 PA14_59840 RL033 1158 Hypothetical protein PAMr_nr_mas_05_4:C10 
27 
PA14_59830 RL034 1482 
Putative DNA 
helicase PAMr_nr_mas_13_3:C1 
28 PA14_59820 RL035 651 Hypothetical protein PAMr_nr_mas_12_2:E10 
29 
PA14_59800 RL036 2796 
sensor of two-
component regulatory 
system  PAMr_nr_mas_01_4:A5 
30 
PA14_59790 pvrR 1200 
regulator of two-
component regulatory 
system; adhesion and 
antibiotic resistance PAMr_nr_mas_15_2:A11 
31 PA14_59780 rcsC 3255 sensor of two- PAMr_nr_mas_05_3:D6 
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component regulatory 
system  
32 
PA14_59770 rcsB 696 
regulator of two-
component regulatory 
system PAMr_nr_mas_10_2:E11 
33 
PA14_59760 cupD5 717 
Probable pili 
assembly chaperone 
/ adhesion and 
protein secretion PAMr_nr_mas_11_3:G6 
34 
PA14_59750 cupD4 1347 
adhesion and protein 
secretion PAMr_nr_mas_03_2:A10 
35 
PA14_59720 cupD2 747 
Probable fimbrial 
biogenesis usher / 
adhesion and protein 
secretion PAMr_nr_mas_04_3:E2 
36 
PA14_59710 cupD1 549 
Probable pili 
assembly chaperone 
/ adhesion and 
protein secretion PAMr_nr_mas_08_4:H11 
37 
PA14_59700 RL046 747 
Probable fimbrial 
precursor / adhesion 
and protein secretion PAMr_nr_mas_12_2:D7 
38 PA14_59690 RL047 2235 Hypothetical protein PAMr_nr_mas_05_4:A2 
39 PA14_59680 RL048 258 Hypothetical protein PAMr_nr_mas_05_4:E9 
40 PA14_59670 RL049 501 Hypothetical protein  PAMr_nr_mas_03_4:A8 
41 PA14_59660 RL050 582 Hypothetical protein PAMr_nr_mas_04_4:A6 
42 PA14_59640 RL052 690 Hypothetical protein PAMr_nr_mas_13_2:B4 
43 PA14_59630 RL054 1032 Hypothetical protein PAMr_nr_mas_13_2:B3 
44 PA14_59620 RL055 666 Hypothetical protein PAMr_nr_mas_05_4:B8 
45 PA14_59610 RL056 675 Hypothetical protein PAMr_nr_mas_09_2:E8 
46 PA14_59600 RL057 246 Hypothetical protein PAMr_nr_mas_09_2:B10 
47 PA14_59590 RL058 360 Hypothetical protein  PAMr_nr_mas_04_4:E5 
48 PA14_59580 RL059 1536 Hypothetical protein PAMr_nr_mas_12_1:C4 
49 PA14_59570 RL060 336 Transposase PAMr_nr_mas_08_2:A12 
50 PA14_59550 RL062 1227 Hypothetical protein  PAMr_nr_mas_03_2:D8 
51 
PA14_59540 RL063 2250 
Plasmid-related 
protein PAMr_nr_mas_05_4:B6 
52 
PA14_59530 RL064 1452 
Plasmid-related 
protein PAMr_nr_mas_12_4:G9 
53 PA14_59520 RL065 606 Hypothetical protein PAMr_nr_mas_11_4:B6 
54 PA14_59500 RL067 363 Hypothetical protein PAMr_nr_mas_09_2:D8 
55 PA14_59490 RL068 276 Hypothetical protein PAMr_nr_mas_15_2:A1 
56 PA14_59480 RL069 690 Hypothetical protein PAMr_nr_mas_08_1:F2 
57 PA14_59470 RL070 351 Hypothetical protein  PAMr_nr_mas_02_1:E1 
58 PA14_59440 RL071 708 Hypothetical protein PAMr_nr_mas_01_4:D4 
59 PA14_59430 RL072 237 Hypothetical protein PAMr_nr_mas_02_2:G6 
60 PA14_59410 RL073 267 Hypothetical protein  PAMr_nr_mas_05_2:E4 
61 PA14_59400 RL074 540 Hypothetical protein PAMr_nr_mas_08_4:A3 
62 PA14_59380 RL075 567 Hypothetical protein  PAMr_nr_mas_04_1:B3 
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63 PA14_59370 RL076 645 Hypothetical protein  PAMr_nr_mas_08_2:F11 
64 
PA14_59360 pilM2 438 
Type IV B pilus / 
adhesion and and 
protein secretion PAMr_nr_mas_14_1:F10 
65 
PA14_59350 pilV2  1329 
Type IV B pilus / 
adhesion and and 
protein secretion PAMr_nr_mas_13_1:H12 
66 
PA14_59320 pilS2  531 
Type IV B pilus / 
adhesion and and 
protein secretion PAMr_nr_mas_05_4:B5 
67 
PA14_59310 pilR2 1080 
Type IV B pilus / 
adhesion and and 
protein secretion PAMr_nr_mas_02_1:H1 
68 
PA14_59290 pilQ2 1581 
ATPase / Type IV B 
pilus / adhesion and 
and protein secretion PAMr_nr_mas_08_2:G5 
69 
PA14_59280 pilP2 534 
Type IV B pilus / 
adhesion and and 
protein secretion PAMr_nr_mas_03_1:B3 
70 
PA14_59270 pilO2 1326 
Type IV B pilus / 
adhesion and and 
protein secretion PAMr_nr_mas_07_3:H2 
71 
PA14_59250 pilN2 1623 
Secretin / Type IV B 
pilus / adhesion and 
and protein secretion PAMr_nr_mas_07_1:D10 
72 
PA14_59240 pilL2 1125 
Type IV B pilus / 
adhesion and and 
protein secretion PAMr_nr_mas_09_2:H8 
73 
PA14_59220 RL088 1497 
Colicin-like toxin 
(pyocin S5) PAMr_nr_mas_02_3:G7 
74 PA14_59210 RL089 1974 DNA Helicase PAMr_nr_mas_15_1:G8 
75 PA14_59200 RL090 1890 Hypothetical protein PAMr_nr_mas_09_3:A6 
76 
PA14_59190 RL091 471 
Similar to luminal 
binding protein PAMr_nr_mas_10_3:D5 
77 PA14_59180 topA 1926 Topoisomerase I PAMr_nr_mas_07_3:A4 
78 PA14_59170 RL093 234 Hypothetical protein  PAMr_nr_mas_12_1:D9 
79 PA14_59160 RL094 246 Hypothetical protein  PAMr_nr_mas_09_3:C10 
80 
PA14_59150 ssb 471 
Single-stranded DNA 
binding protein PAMr_nr_mas_06_4:H2 
81 PA14_59140 RL096 534 Hypothetical protein PAMr_nr_mas_06_4:C3 
82 PA14_59130 RL097 729 Hypothetical protein PAMr_nr_mas_06_3:D2 
83 PA14_59120 RL098 240 Hypothetical protein  PAMr_nr_mas_13_2:B8 
84 PA14_59100 RL100 1326 Hypothetical protein PAMr_nr_mas_08_2:G6 
85 PA14_59090 RL101 768 Hypothetical protein PAMr_nr_mas_09_1:G8 
86 PA14_59060 RL103 255 Hypothetical protein  PAMr_nr_mas_05_1:G3 
87 PA14_59050 RL104 1017 Hypothetical protein PAMr_nr_mas_04_3:F6 
88 PA14_59010 RL107 258 Hypothetical protein  PAMr_nr_mas_05_1:A6 
89 PA14_59000 RL108 528 Hypothetical protein  PAMr_nr_mas_12_1:E2 
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90 PA14_58990 pseudo 1363 
DNA replication and 
recombination 
PAMr_nr_mas_13_1:E5 
91 
PA14_58970 RL110 708 
Putative phage 
protein PAMr_nr_mas_01_4:H11 
92 PA14_58950 RL112 687 Hypothetical protein PAMr_nr_mas_05_1:C5 
93 PA14_58930 RL113 498 Hypothetical protein  PAMr_nr_mas_08_3:H10 
94 PA14_58920 RL114 681 Hypothetical protein  PAMr_nr_mas_06_1:B7 
95 
PA14_58910 soj 930 
Chromosome 
partitioning PAMr_nr_mas_15_1:F2 
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Table 4. Primers used in this study 
 
Primer  Sequence (5’-3’) Description Source 
TnC2-US-F GGTACCGGCAACACATTTCTCCCTCG 
Amplify a 
fragment of 532 
bp upstream of 
PA14_59200 
gene 
This 
study 
TnC2-US-R TCTAGATTGAGCCAGCCAGTTGTAGA 
TnC2-DS-F TCTAGACGGCTGAGAGACATCAAGGA 
Amplify a 
fragment of 594 
bp downstream 
of PA14_59200 
gene 
This 
study 
TnC2-DS-R AAGCTTGTTCAGGTTCGTCGCTATGG 
Tc-F TCTAGATCAGGTCGAGGTGGCCC Amplify Tet gene 
from mini-CTX2 
plasmid 
This 
study 
Tc-R TCTAGAAGAGCGCTTTTGAAGCTAATTCGCTG 
TnC2-Li-F CTTGACGAGTTTGCTGCACT Check the insert 
of Tet gene on 
the left junction 
This 
study 
TnC2-Li-R GAGAAGCAGGCCATTATCGC 
TnC2-Ri-F GAACGGGTGCGCATAGAAAT Check the insert 
of Tet gene on 
the right junction 
This 
study 
TnC2-Ri-R TTCGACCAAGGAGCTGAACT 
pilV2-F ATAGGATCCCTGTCCTGCCAAAACGGG Amplify C-
terminal region 
of pilV2 gene 
(97 amino acid) 
This 
study 
pilV2-R ATATGAATTCCTAGTTCACGCAGGTAACGG 
intF AGCTACATCGAGGCCGACTA 
Check the 
insertion of 
PAPI-1 on the 
left junction of 
attL site 
[91] 
4542F GTGGTGATGACCTCCAACCT [91] 
sojR CGAGCACAGAAATGTCCTGA 
Check the 
insertion of 
PAPI-1 on the 
right junction of 
attR site 
[91] 
4541F GACAAGACCAGCCACAACCT 
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3.2. Screening for PAO1 mutants deficient in PAPI-1 acquisition 
 
A standard PAPI-1 transfer assay via liquid mating was carried out as previously 
described [93]. Mutant PA14TnC2::GmR was used as donor and a series of 
PAO1 mutants (TcR) with altered LPS biosynthesis from PAO1 transposon mutant 
library [115] [106] were used as recipients. The list of PAO1 mutants for this 
experiment was presented in the table 2. After overnight growth at 37 oC and 200 
rpm, the donor cells were harvested at an OD600 of 0.8 and were mixed with the 
recipient cells at an OD600 of 0.4, spun down and resuspended in 1 ml of fresh LB 
without antibiotics. The mating mixture was incubated in 15 ml culture tubes, 
statically at 37 °C for 24 h. The mating mixture was diluted to appropriate 
concentrations and plated on LB agar plates containing gentamicin and 
tetracycline at 75 µg/ml to select for transconjugants, and on LB agar plates 
containing only tetracycline at 75 µg/ml to select for recipients. The transfer 
efficiency was calculated as the transconjugants / recipients ratio of colonies in the 
mating mixture. 
3.3. Outer membrane (OM) preparation  
 
The outer membranes of P. aeruginosa were isolated by using sodium 
lauroylsarkosinate (sarkosyl) as described previously [117]. Briefly, cultures of P. 
aeruginosa were grown overnight at 37 °C, 200 rpm in LB broth. The pre-inoculum 
was then diluted 100-fold in fresh LB medium and grown at 37 °C and 200 rpm to 
an OD600 of 1.0. Cells were harvested and resuspended in 15 ml lysis buffer 
containing 20 mM Tris-Cl [pH 7.5], 100 mM NaCl, 1mM EDTA, lysozyme [0.5 
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mg/ml] and a complete protease inhibitor cocktail (Roche). The lysate was 
sonicated and spun down at 10,000 g, 10 min, 4 °C to remove cellular debris. The 
membrane fraction was isolated by ultracentrifugation (200,000 g at 4°C for 60 
min). The pellets containing inner and outer membranes were further fractionated 
at 100,000 g for 30 min after incubation with sarkosyl 0.2%. OMs were finally 
resuspended in Tris-Cl buffer 20 mM [pH 7.5] and separated on 12% sodium 
dodecyl sulfate (SDS)-polyacrylamide gels and stained with Coomassie blue. The 
concentration of OMs was measured by protein assay kit (Biorad). 
3.4. LPS preparation 
 
LPS molecules from various P. aeruginosa strains were prepared by using the hot 
phenol-water extraction protocol from Westphal and Jann (1965) with minor 
modifications [118]. Briefly, cell suspensions in 100 mM NaCl were first heated to 
68oC before adding an equal volume of hot phenol and stir vigorously for 2 hours 
at 68°C. LPS was then fractionated by centrifugation at 12,000g for 15 min at 4°C. 
LPS in the upper phase was recovered and dialyzed against water to remove 
phenol residue. LPS extract was further treated with DNase, RNase and 
proteinase K to eliminate contaminations. LPS extract was finally lyophilized before 
use. The LPS samples were separated by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) followed by silver staining. LPS was then 
quantified with KDO assay [119]. 
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3.5. LPS silver staining 
 
LPS preparations were separated with 12% discontinuous PAGE gel and 
visualized by silver staining, previous described [120]. Shortly, LPS gel was 
incubated 22 °C for 20 min without prior fixation in oxidation solution containing 
0.7% periodic acid in 40% ethanol and 5% acetic acid. The gel was washed with 
distilled water in 5 min for three times. The gel was stained for 10 min in a fresh 
staining solution, containing a 4-ml volume of concentrated ammonium hydroxide 
that was added to 56 ml of 0.1 M sodium hydroxide, 200 ml of water, 10 ml of 20% 
(wt/vol) silver nitrate (Sigma, Germany) was added in drops with stirring and 30 ml 
with water. The gel was washed again three times with distilled water for 5 min. 
The yellow color was rapidly developed in 200 ml solution of 10 mg of citric acid 
and 0.1 ml of 37% formaldehyde. The color exposure was stopped in 10% acetic 
acid for 1 min followed by washing in distilled water. 
3.6. PAPI-1 transfer inhibition assay 
 
OM and LPS preparations at various concentrations were added to a standard 
mating assay based on plasmid conjugal transfer [121], between the donor 
PA14TnC2::GmR and the recipient PAO1::TcR. A mating mixture without addition 
of OM or LPS was also included as a negative control for this experiment. The 
transfer inhibition index was calculated by dividing the transfer efficiency observed 
with the addition of OM or LPS to that of the control.  
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3.7. Construction of PA14TnC2::TcR mutant 
 
The mutant PA14TnC2 is proficient in transfer of PAPI-1 and has been used as a 
donor in PAPI-1 transfer assay [93]. In some experiments, a donor with TcR 
marker was required since the recipient containing GmR, and we expected to have 
an equivalent transfer efficiency to the PA14ΔTnC2::GmR obtained from PA14 
transposon mutant library in which the transposon also inserted at nucleotide 1634 
of PAPI-1 gene RL090 (PA14_59200). Therefore, the PA14_59200 gene of the 
wild-type PA14 was partially deleted and replaced by a tetracycline resistant 
marker. The mutant was constructed by using gene replacement vectors and 
methods, as previously described [122]. All primers used for generating the mutant 
PA14TnC2::TcR are listed in Table 4. Briefly, DNA fragments of 500 bp, located at 
5’ and 3’ end of the PA14_59200 gene and tetracycline resistance gene, were 
amplified and cloned in the vector pJET1.2 before subcloning into the vector 
pEXG2. The recombinant plasmid was conjugated from E. coli  pir S17.1 into P. 
aeruginosa [123]. The integrative plasmids were selected on LB plates 
supplemented with gentamicin, tetracycline or irgasan at 25μg/ml. To resolve 
merodiploids, which are cells possessing a partial duplication of their genetic 
material and potentially allows evolution of new genes [124], a second selection 
round on LB agar with 6% sucrose was performed. Transformants were screened 
by colony PCR and confirmed by DNA sequencing. 
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3.8. Expression of GST-pilV2 fusion protein 
 
C-terminal region of pilV2 gene encoding 97 residues was amplified with the 
primers listed in Table 4 and cloned into pJet 1.2/Blunt before transformation into E 
.coli DH5α. The insert was then cloned into the expression vector pGEX-2T (Life 
Technologies) and transformed into E. coli BL21. Escherichia coli BL21 containing 
pGEX-2T-pilV2’ was grown to an OD600 of 0.6 and IPTG at 0.1 mM was added to 
induce gene expression and translation of GST-pilV2’ protein. The expression step 
was carried out at 37oC, 200 rpm for 3 hours. The culture was centrifuged at 8000 
rpm, 4oC for 20 min to pellet the cells. GST-pilV2’ fusion protein was then purified 
by using glutathione Sepharose 4B (GE Healthcares), as previously described 
[125]. The GST-pilV2’ protein expression was also confirmed by anti-GST primary 
antibody (GE Healthcare) followed by anti-goat IgG Alkaline Phosphatase 
Conjugate and detected by using BCIP/NBT color development subtrate. 
3.9. Western blotting for LPS samples 
 
LPS samples prepared by Hitchcock and Brown method (1983) were used for 
western blotting analyses. The western blot protocol for LPS was described 
previously [118]. Briefly, 3 ul of LPS extract was loaded into a 12% discontinuous 
PAGE gel and run at 200 V for 50 min. LPS was electrophoretically transferred 
onto nitrocellulose membrane at 180 mA for 60 min. The membrane was blocked 
with 5 % skim milk for 20 min at room temperature, washed in PBS for 10 min 
before adding primary antibodies directed against different parts of LPS structure, 
and incubated overnight. Secondary antibodies were added after a 10-min wash 
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and followed by 1 hour of incubation. The membrane was washed again for 10 min 
and developed by using BCIP/NBT color development subtrate.  
3.10. Microtiter plate binding assay 
 
Binding of LPS to GST-pilV2’ fusion was quantified by an enzyme-linked plate 
assay essentially as previously described [126] with slight modifications. Microtiter 
plates (Corning) were coated with 10 μg/ml LPS from PAO1 and PAO1 with PAPI-
1 suspended in PBS (0.137 M NaCl, 0.005 M KCl, 0.009 M Na2HPO4, and 0.001 M 
KH2PO4 (pH 7.4)) containing 0.05% Tween 20 (v/v, PBST). The plates were then 
washed with PBST and blocked with 3% BSA. GST-pilV2’ fusion was added to the 
wells coated with LPS and incubated for 2 h at room temperature. After three 
washes with PBST, mouse anti-GST antibody was added and incubated for 1.5 h. 
Then, HRP-labeled anti-mouse Ig (Sigma-Aldrich) was added after three other 
washes. TMB solution (Thermo Scientific) was used for color development and 
ODs were measured at 450 nm. LPS from Salmonella enterica was used as a 
negative control.  
3.11. Screening for PAPI-1 genes involved in exclusion activity of 
Pseudomonas aeruginosa 
 
The screening was followed the previous protocol (section 3.2). A standard PAPI-1 
transfer assay via liquid mating was also carried out here between the mutant 
PA14TnC2::TcR used as donor and a series of ninety-five PA14 mutants for 
PAPI-1 genes from PA14 transposon mutant library as recipients containing 
gentamicin resistant marker, listed in the table 3 [116]. The mating mixtures were 
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statically incubated at 37 °C for 24 h and then diluted to appropriate 
concentrations. Number of transconjugants was counted on LB agar plates with 
gentamicin and tetracycline at 75 µg/ml and that of recipients was selected on LB 
agar plates containing tetracycline at 75 µg/ml.  
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4. RESULTS  
4.1. PAO1 mutants for A-band LPS biosynthesis are deficient in the 
acquisition of PAPI-1  
Since in conjugal plasmid system the donor pilus is known to interact with specific 
components of LPS on the recipient membrane to initiate the transfer  [101], we 
examined the effects of using various PAO1 mutants for LPS biosynthesis as 
recipients on PAPI-1 transfer assay (Figure 12). The mutant PA14TnC2::GmR 
has previously been proposed as a proficient donor in PAPI-1 transfer [93], and 
was used as a donor in this study.  We first checked the transfer efficiency of 
PAPI-1 into the mutant PAO1∆algC, in which algC gene was disrupted by 
transposon insertion at nucleotide 628 [115]. The gene algC encodes for a 
phosphoglucomutase, which is required for the synthesis of a complete LPS 
structure [127]. The mutant PAO1algC thus produces a truncated LPS core and 
is devoid of O-antigen. When the transfer assay was carried out between the 
donor PA14TnC2::GmR and PAO1algC::TcR, the transfer efficiency was reduced 
by three orders of magnitude compared to that of wild-type PAO1 (Figure 12A). 
This suggests that the complete LPS structure plays an important role in PAPI-1 
acquisition. We therefore decided to screen a series of 32 PAO1 mutants for LPS 
biosynthesis (Table 2) [106] using them as recipients in the PAPI-1 transfer assay. 
These mutants were obtained from PAO1 transposon mutant library, which contain 
TcR [115].  
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The results showed that transfer efficiency of PAPI-1 into 10 PAO1 mutants 
including PA5001; PA5447 (wbpZ); PA5448 (wbpY); PA5449 (wbpX); PA5450 
(wzt); PA5453 (gmd); PA5454 (rmd); PA5455; PA5456 and PA5459 was 
significant decreased of two to three orders of magnitude compared to control. All 
these genes, except PA5001, were predicted as members of 2 operons [128]. One 
starts from 6135968 to 6144991 (8 constituent genes) and another is from 
6145399 to 6151151 (5 genes). Interestingly, some of these genes are known to 
be involved in Common Polysaccharide Antigen (CPA) biosynthesis (Table 5). 
They encode enzymes responsible for the CPA biosynthesis pathway as shown in 
Figure 11. The CPA or A-band LPS has been shown to contain a tri-saccharide 
repeating unit: [3)-α-D-Rha-(13)-α-DRha-(12)-α-D-Rha-(1]n, so-called D-
rhamnose homopolymer or rhamnan structure. This structure has been 
characterised several times with good agreement between different studies [129], 
[130]. As a result, our data suggested that the A-band LPS could act as a receptor 
for conjugative type IV pilus as an initial step of PAPI-1 transfer.  
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Table 5. Genes involved or potentially involved in Common Polysaccharide 
Antigen (A-band LPS) biosynthesis. This table was reproduced by King et al., 
2009 [106]. 
 
Gene Related proteins (% identity) 
Proposed/demonstrated 
function 
Key 
reference 
wbpZ/PA5447 52% E. coli O9a WbdC Glycosyltransferase (GT-4) [131] 
wbpY/PA5448 34% E. coli O9a WbdB Glycosyltransferase (GT-4) [131] 
wbpX/PA5449 
33% E. coli O9a WbdA C-
terminal domain (over 301 
amino acids) 
Glycosyltransferase (GT-4) [131] 
 
25% E. coli O9a WbdA N-
terminal domain (over 262 
amino acids) 
  
wzt/PA5450 61% E. coli O8 Wzt ABC transporter [132] 
wzm/PA5451 56% E. coli O8 Wzm ABC transporter [132] 
wbpW/PA5452 46% P. aeruginosa AlgA 
D-Man-6-phosphate 
isomerase / GDP-D-Man 
pyrophosphorylase 
[133] 
 
60% P. aeruginosa PslB 
  
gmd/PA5453 47% E. coli GMD 
GDP-D-Man 4,6-
dehydratase 
[134] 
rmd/PA5454 
33% Aneurinibacillus 
thermoaerophilus RMD 
GDP-D-Rha synthase [134] 
PA5455 
 
Glycosyltransferase (GT-4) 
 
PA5456 
 
Glycosyltransferase (GT-4) 
 
PA5457 
20% E. coli O8 WbdD (over 
149 amino acids) 
Methyltransferase 
 
PA5458 
24% Staphylococcus aureus 
OatA 
Acetyltransferase 
 
PA5459 
23% E. coli O8 WbdD (over 
139 amino acids) 
Methyltransferase 
 
algC/PA5322 31% E. coli ManB 
Phosphomannomutase/ph
osphoglucomutase 
[135] 
The classification of Glycosyltransferase (GT) family is provided by the CAZy 
database [136]. * References including experimental study with P. aeruginosa 
genes are cited. 
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Figure 11. The GDP-D-rhamnose biosynthesis pathway. All the enzymes are 
encoded by a gene cluster, except the second enzyme phosphomannomutase 
encoded by algC gene in the alginate locus. D-fructose-6-phosphate; 1, Pi, 
phosphate; 2, mannose-6-Pi; 3, GDP-D-Man; 4, α-mannose-1-Pi; 5, GDP-4-keto-
D-Rha; 6. This figure was modified from King et al., 2009 [106]. 
 
 
 
 
 
 
68 
 
 
 
Figure 12. PAPI-1 transfer efficiency using PAO1 mutants for LPS biosynthesis 
genes as recipient strains. (A) Transfer efficiency into PAO1algC (B) Transfer efficiency 
into various PAO1 mutants for LPS biosynthesis. Positive control (POS): PAO1::TcR and 
Negative control (NEG): PAO1algC. Results were shown as mean ± SD for three 
independent replicates. Statistical significance was calculated by the unpaired t-test (A) 
and One-way ANOVA compared to the positive control (B) (ns: no significant; and *** p < 
0.001). 
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4.2. Addition of OM and A-band LPS preparations inhibits PAPI-1 transfer  
We hypothesized that OM fractions or A-band LPS preparations, the putative 
receptor for conjugative pilus, can compete with the recipients binding to the 
conjugative pilus and thus block the transfer of PAPI-1 to the recipient. We thus 
extracted OM and LPS from two PAO1 mutants producing only A-band LPS and 
two others producing only B-band LPS. The quality of OM and LPS preparations 
was controlled by SDS-PAGE (Figure 13) before adding them to the standard 
PAPI-1 transfer assay at different concentrations. As mentioned in the introduction 
section, the outer membrane fraction of P. aeruginosa contains at least six main 
proteins, including D (50 kDa), E (45 kDa), F (33 kDa), G and H (21 KDa), I (8 
kDa) [104] (Figure 13A). The LPS preparations were processed to be free of 
protein, DNA and RNA contamination. In this experiment, OM and LPS samples 
were fractionated from two PAO1 mutants producing A-band LPS (PAO1wbpM 
[137] and PAO1wzx [138]) and two others for B-band LPS (PAO1rmd [133] and 
PAO1algC).   
Our results showed that the increased addition of OM and LPS amount from 
mutants lacking B-band LPS inhibited transfer efficiency, while the addition of OM 
and LPS from mutants lacking A-band LPS did not produce any significant effect 
on PAPI-1 transfer efficiency. The addition of OM and LPS from PAO1wbpM and 
PAO1wzx strongly inhibited transfer even at low concentrations (< 5 g) and 
reached the maximum index at 80% (Figure 14). These results strongly support 
the hypothesis that A-band LPS functions as a specific receptor for the IVb pilus in 
the recipient strain, and that it is required to initiate the transfer of PAPI-1. 
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Moreover, statistical analysis using two-way ANOVA for two factors (type and 
amount of OM or LPS) revealed that OM and LPS derived from A-band producing 
mutants have significant effects on PAPI-1 transfer efficiency compared to those 
from B-band producing ones with P < 0.001 (Table 6 and 7). The half maximal 
inhibitory concentration (IC50), corresponding to the amount of preparations 
inhibiting 50% of the transfer efficiency, were calculated (Table 8). IC50 of OM from 
both PAO1∆wzx and PAO1∆wbpM are 0.866 µg, whereas IC50 for LPS were of 
1.184 µg for PAO1∆wzx and 2.114 µg for PAO1∆wbpM.  
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Figure 13. OM (A) and LPS (B) preparations from PAO1 mutants lacking either A-
band or B-band LPS.  Well 1, PAO1wbpM (A+, B-); Well 2, PAO1wzx (A+,B-); Well 3, 
PAO1rmd (A-,B+); Well 4, PAO1algC (A-, B+). 
 
Figure 14. Effect on PAPI-1 transfer efficiency of the addition of OM (A) and LPS (B) 
preparations from PAO1 mutants lacking either A-band or B-band LPS.  Red, 
PAO1rmd (A-,B+); green, PAO1algC (A-, B+); blue, PAO1wbpM (A+, B-); purple, 
PAO1wzx (A+,B-).  
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Table 6. Statistical analysis for the effects of OM from PAO1 mutants lacking 
either A-band or B-band LPS on PAPI-1 transfer efficiency. Significant 
differences were analyzed by two-way ANOVA for two factors (type and amount of 
OM) 
PAO1∆wbpM (+A -B) vs PAO1∆rmd (-A +B) 
Amount of OM (ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
0.5 8.482 4.67 P<0.001 *** 
1 27.57 15.18 P<0.001 *** 
2 50.1 27.58 P<0.001 *** 
5 51.36 28.27 P<0.001 *** 
10 66.31 36.51 P<0.001 *** 
15 69.84 38.45 P<0.001 *** 
PAO1∆wbpM (+A -B) vs PAO1∆algC (-A +B) 
Amount of OM (ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
0.5 7.742 3.679 P<0.01 ** 
1 22.81 10.84 P<0.001 *** 
2 47.44 22.55 P<0.001 *** 
5 50.05 23.79 P<0.001 *** 
10 57.74 27.44 P<0.001 *** 
15 64.72 30.76 P<0.001 *** 
PAO1∆wzx (+A -B) vs PAO1∆rmd (-A +B) 
Amount of OM (ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
0.5 15.49 9.14 P<0.001 *** 
1 41.05 24.22 P<0.001 *** 
2 54.08 31.91 P<0.001 *** 
5 68.34 40.32 P<0.001 *** 
10 75.07 44.29 P<0.001 *** 
15 76.67 45.23 P<0.001 *** 
PAO1∆wzx (+A -B) vs PAO1∆algC (-A +B) 
Amount of OM (ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
0.5 14.75 7.375 P<0.001 *** 
1 36.29 18.14 P<0.001 *** 
2 51.42 25.71 P<0.001 *** 
5 67.03 33.51 P<0.001 *** 
10 66.5 33.24 P<0.001 *** 
15 71.55 35.77 P<0.001 *** 
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Table 7. Statistical analysis for the effects of LPS from PAO1 mutants lacking 
either A-band or B-band LPS on PAPI-1 transfer efficiency. The significant 
differences were analyzed by two-way ANOVA for two factors (type and amount of 
LPS) 
PAO1∆wbpM (+A -B) vs PAO1∆rmd (-A +B) 
Amount of LPS 
(ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
1 36.21 6.104 P<0.001 *** 
5 70.02 11.8 P<0.001 *** 
10 63.77 10.75 P<0.001 *** 
15 78.19 13.18 P<0.001 *** 
PAO1∆wbpM (+A -B) vs PAO1∆algC (-A +B) 
Amount of LPS 
(ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
1 25.65 4.372 P<0.01 ** 
5 58.77 10.02 P<0.001 *** 
10 62.57 10.66 P<0.001 *** 
15 66.01 11.25 P<0.001 *** 
PAO1∆wzx (+A -B) vs PAO1∆rmd (-A +B) 
Amount of LPS 
(ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
1 20.44 4.214 P<0.01 ** 
5 59.51 12.27 P<0.001 *** 
10 56.82 11.71 P<0.001 *** 
15 76.02 15.67 P<0.001 *** 
PAO1∆wzx (+A -B) vs PAO1∆algC (-A +B) 
Amount of LPS 
(ug) Difference t P value Summary 
0 0 0 P > 0.05 ns 
1 9.89 2.072 P > 0.05 ns 
5 48.26 10.11 P<0.001 *** 
10 55.62 11.65 P<0.001 *** 
15 63.84 13.38 P<0.001 *** 
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Table 8. Analysis of half maximal inhibitory concentration (IC50) for the 
addition of OM and LPS from the mutants producing only A-band into the 
PAPI-1 transfer assay. IC50 was calculated by an equation “log(inhibitor) vs. 
normalized response -- Variable slope” with software GraphPad Prism 5. 
  
Additives 
OM LPS 
PAO1∆wzx 
(+A, -B) 
PAO1∆wbpM 
(+A, -B) 
PAO1∆wbpM 
(+A -B) 
PAO1∆wzx 
(+A -B) 
Best-fit values         
LogIC50 -0.06247 -0.06247 0.0735 0.325 
IC50 0.866 0.866 1.184 2.114 
P value 0.6114 0.0084 
Preferred 
model 
LogIC50 SAME for all data sets  
LogIC50 DIFFERENT for each data 
set 
 
4.3. Construction of the PA14∆TnC2::TcR mutant 
Since some experiments required a donor with tetracycline resistant marker, we 
constructed the mutant PA14∆TnC2 by inserting tetracycline gene within 
PA14_59200 (or TnC2 gene), and named it PA14∆TnC2::TcR. We expected to 
obtain a donor providing an equivalent transfer efficiency as PA14∆TnC2 which 
was throughout used in this study. We constructed a pJet 1.2/blunt plasmid 
containing an fragment ranging from 500-600 bp at 5’ and 3’ end of the TnC2 gene 
with Tet resistance gene inserted in the middle. We obtained specific PCR 
amplicons in a range of annealing temperatures (60 to 65oC) (Figure 15). All 
fragments were successfully ligated in a correct order into pJet 1.2/blunt, 
subcloned in pEXG2, and used to transform into wild-type P. aeruginosa PA14. 
Eventually, the correct mutation in TnC2 gene was confirmed by PCR assay for left 
and right junctions (Figure 16). The transfer efficiency of PAPI-1 into PAO1 
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recipient for PA14∆TnC2::TcR was comparable to that of PA14∆TnC2::GmR (data 
not shown). 
 
 
 
 
Figure 15. PCR amplification of upstream and downstream fragments and 
PA14_59200 gene with gradient annealling temperature (60oC; 62,5oC; 65°C). Well 1-3: 
amplicon of US fragment; Well 4-6: amplicon of DS fragment; Well 7-9: amplicons of 
tetracycline resistant gene. Well 10: negative control. 
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Figure 16. PCR amplification confirming the insertion of tetracycline resistance 
cassette in PA14_5900 gene. Well 1-2: Right insertion of two tested colonies (Primers 
TnC2-Ri-F and TnC2-Ri-R); Well 3-4: Left insertion of two tested colonies (Primers TnC2-
Li-F e TnC2-Li-R). 
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4.4. Recipient strains carrying PAPI-1 can acquire additional copies of the 
island at a low frequency 
 
After having demonstrated that the conjugative transfer is mediated by contact with 
A-band LPS, we asked if the recipients already carrying PAPI-1 can acquire 
additional copies of this island. In this experiment, we carried out a combination of 
mating assays between the donors PA14+ or PAO1+ and the recipients also with 
PAPI-1 (PA14+ or PAO1+) or without PAPI-1 (PA14 – or PAO1 – ). 
 
As shown in Figure 17, the transfer efficiency of PA14+ to PA14- is significant 
lower than the control PAO1-. This would suggest that the transfer efficiency of 
PAPI-1 is also influenced by the identity of the recipient strain. Remarkably, it can 
be noted that the strain PAO1 carrying PAPI-1 can act as a donor of the island, 
transferring it to the control recipient (PAO1-) at a similar efficiency as that of 
PA14+. These results also demonstrate the ability of recipient strains to acquire 
more than one PAPI-1 copy, even if this occurs at much lower efficiency compared 
to controls, with a decrease of one and three orders of magnitude and three orders 
of magnitude for PA14+/PA14+ and PAO1+/PAO1+, respectively. Our data thus 
indicates that P. aeruginosa which already acquired PAPI-1 strongly and 
significantly decreased their ability of receiving additional copies. This implies that 
P. aeruginosa strains carrying PAPI-1 specify a mechanism to exclude the 
acquisition of additional copies of the island.  
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4.5. The acquisition of PAPI-1 specifies a surface exclusion mechanism 
We hypothesized that after acquisition of PAPI-1, recipient P. aeruginosa strains 
modify their membrane structure to avoid further contact and transfer with the 
donor cells. To infer if the presence of PAPI-1 in the cell genome can affect the 
structure of its OM and LPS, we performed again the standard transfer assay with 
the addition of OM and LPS from strains with and without PAPI-1. Similar to 
section 4.2, the quality of OM and LPS was controlled before added to the transfer 
assay (Figure 18). As shown in Figure 19, the addition of OM preparations derived 
from strains with PAPI-1 do not impact on transfer efficiency, compared to the 
ones with OM of the strains without the island. The effect of LPS preparations 
(Figure 19B) is similar for PAO1 strain but not for PA14, since the addition of LPS 
from PA14- did not produce significant variation in transfer efficiency. This data 
suggests that P. aeruginosa specify mechanisms to exclude the acquisition of 
additional copies of PAPI-1 via OM and/or LPS modification. However, the 
mechanism seems to be different for PAO1 and PA14. The statistical analysis also 
showed that the effect of OM from PAO1 and PA14 strains with or without PAPI-1 
are significant different (P<0.001) (Table 9). However, only the effect of LPS from 
PAO1+ and PAO1- is significant; but not for PA14 (Table 10). The half maximal 
inhibitory concentration (IC50) values of OM and LPS from strains without PAPI-1 
were also analyzed (Table 11). For OM, the IC50 of PAO1- (0.9726 µg) was lower 
than that of PA14- (1.453 µg). For the LPS of PAO1-, the IC50 was 1.232 µg.  
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Figure 17. Transfer efficiency of multiple PAPI-1 copies into recipient strains. 
Marks [+] or [-] stand for strains with or without PAPI-1, respectively. After 
acquisition of PAPI-1, PAO1 becomes a stable donor which can transfer PAPI-1 to 
another recipient and decreases its ability of receiving additional copies of PAPI-1. 
Results are presented as mean ± SD for three independent experiments. Statistical 
significance was calculated by the unpaired t-test (A) (** p<0.01, and *** p<0.001). 
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Figure 18. OM (A) and LPS (B) preparations from strains with or without 
PAPI-1 island. OM preparations were stained with Coomassie 1%. LPS samples 
were visualized by silver staining. Well 1, PAO1+; Well 2, PAO1-; Well 3, PA14+; 
Well 4, PA14-. 
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Figure 19. Effect on PAPI-1 transfer of the addition of OM (A) and LPS (B) 
preparations derived from strains with (+) or without (-) PAPI-1 island. Pink, 
PAO1-; orange, PAO1+; gray, PA14+; blue, PA14-. Purple data point on (B) are LPS 
from Salmonella enterica used as negative control.  
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Table 9. Statistical analysis for the effects of OM preparations from the 
strains with and without PAPI-1. The significant differences were analyzed by 
two-way ANOVA for two factors (type and amount of OM). 
PAO1- vs PAO1+ 
Amount of OM Difference t P value Summary 
0 0 0 P > 0.05 ns 
0.5 11.27 6.377 P<0.001 *** 
1 35.65 20.17 P<0.001 *** 
2 60.47 34.22 P<0.001 *** 
5 67.47 38.18 P<0.001 *** 
10 67.54 38.22 P<0.001 *** 
15 70.47 39.88 P<0.001 *** 
PA14- vs PA14+ 
Amount of OM Difference t P value Summary 
0 0 0 P > 0.05 ns 
0.5 4.863 3.353 P < 0.05 * 
1 -14.5 9.995 P<0.001 *** 
2 -37.4 25.79 P<0.001 *** 
5 -51.22 35.31 P<0.001 *** 
10 -45.74 31.54 P<0.001 *** 
15 -55.29 38.12 P<0.001 *** 
 
 
 
 
 
 
 
 
83 
 
Table 10. Statistical analysis for the effects of LPS preparations from the 
strains with and without PAPI-1. The significant differences were analyzed by 
two-way ANOVA for two factors (type and amount of LPS). 
PAO1- vs PAO1+ 
Amount of LPS Difference t P value Summary 
0 0 0 P > 0.05 ns 
1 27.93 5.937 P<0.001 *** 
5 59.62 12.67 P<0.001 *** 
10 54.93 11.68 P<0.001 *** 
15 69.82 14.84 P<0.001 *** 
     PA14- vs PA14+ 
Amount of LPS Difference t P value Summary 
0 0 0 P > 0.05 ns 
1 2.71 0.3892 P > 0.05 ns 
5 -12.11 1.739 P > 0.05 ns 
10 4.92 0.7066 P > 0.05 ns 
15 -1.65 0.237 P > 0.05 ns 
 
Table 11. Analysis of half maximal inhibitory concentration (IC50) for the 
addition of OM and LPS from the mutants without PAPI-1 into the PAPI-1 
transfer assay. IC50 was calculated by an equation “log(inhibitor) vs. normalized 
response -- Variable slope” with software GraphPad Prism 5. 
 
Additives 
OM LPS 
PA01 - PA14 - PAO1- 
Best-fit values       
LogIC50 -0.01205 0.1622 0.0906 
HillSlope -1.897 -2.565 -1.119 
IC50 0.9726 1.453 1.232 
P value P<0.0001   
Preferred model 
LogIC50 DIFFERENT 
for each data set   
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4.6. Reduction of A-band LPS production plays a role in the surface 
exclusion mechanism of PAPI-1 
We wanted to better understand the putative mechanism that P. aeruginosa uses 
to exclude additional copies of PAPI-1. We therefore asked if the strains containing 
PAPI-1 could modify their LPS structure, which would result in the reduction of 
LPS binding capacity to the donor’s pilus. With silver staining of LPS, no 
differences between the same strain with or without PAPI-1 could be observed 
(Figure 20A). Then, Western blotting using a combination of antibodies (MF15-4 
[139], [140]; N1F10 [139], [141]; 5c7-4 [139], [142]; 5c101 [139], [142] recognizing 
different parts of LPS from PAO1+ and PAO1- was carried out. This experiment 
could not be performed for PA14 strains because the corresponding antibodies are 
not available. 
We observed that there were no differences between different parts of LPS, with 
the notable exception of the A-band receptor, since PAO1+ seemed to produce 
significant less amount of A-band LPS compared to PAO1- (Figure 20B). An 
possible explanation for this is that after acquiring PAPI-1 island, PAO1 recipients 
represses the expression of genes involved in the biosynthesis of A-band LPS, 
leading to a reduced ability to bind the conjugative pilus and thus to act as a 
recipient for PAPI-1. 
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Figure 20. Analysis of LPS preparations from PAO1 and PA14 strains with (+) 
or without (-) PAPI-1. (A) LPS silver staining. (B) Western_blot with a combination 
of antibodies specifically recognizing A-band (N1F10), B-band (MF15-4), outer 
core (5c101) and inner core (5c7-4). 
 
4.7. Expression and purification of pilV2’ pilin 
PilV2’ is a small pillin protein constituting the type IVb pilus [93] showing significant 
similarity to adhesions PilVB and PilVA’ of plasmid R64, with 40% of identity (data 
not shown). C-terminal variable segments of R64 pilV adhesins were previously 
shown to interact with LPS of recipient in vitro [44]. Therefore, we engineered a 
glutathione transferase (GST) fusion protein carrying at its C-terminus a 97 amino 
acid C-terminal segment of PilV2’, so-called GST-pilV2’ fusion, containing 
analogue constructs of R64 PilV adhesin.  
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Two E.coli BL21 colonies containing pGEX with GST- pilV2’ construct were tested 
the expression of the target protein. As shown in Figure 21, a band appears at the 
expected size of 36 kDa for GST-pilV2’ with increased concentrations after 
induction. This suggests the target protein was well expressed in the studied 
condition. Furthermore, the small-scale purification process was also established 
for GST-pilV2’. The result showed that GST-pilV2’ protein was mostly expressed in 
the insoluble fraction (lysis pellet), while there was very low concentration of the 
target protein recovered in the soluble phase (Figure 22). N-laurylsarkosine 
(sarkosyl) and Triton X-100 was added to lysis buffer to aid in solubilization of the 
fusion protein. It was observed that GST-pilV2’ protein was well solubilized with 
this protocol (Figure 23).  
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Figure 21. Expression of GST-pilV2’ fusion protein in two tested colonies. 
Samples were taken at 0h, 2h, 3h of induction of IPTG 0.1mM at 37 oC and 200 
rpm. 
 
Figure 22. Western-blotting on different purification steps for GST-pilV2’ 
fusion protein using anti-GST antibody. Well 1: 0h of induction (as a negative 
control); Well 2-5: samples from the culture of colony 1 (3h induction; insoluble 
fraction; soluble fraction; purifed fraction after reduced from GST resin binding 
respectively). Similarly, well 6-9: samples from the culture of colony 2 with the 
same order. 
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Figure 23. Solubilization of GST-pilV2’ fusion protein with Sarkosyl. Well 1: 3h 
induction; well 2: Crude lysate; Well 3: Soluble fraction with Sarkosyl; Well 4: 
Insoluble fraction. 
 
4.8. LPS derived from PAO1 strain carrying PAPI-1 strongly reduces the 
binding capacity to conjugative pilus 
To confirm that PAO1+ strain lost the recognition of donor’s conjugative pilus, we 
over-expressed and purified a GST-pilV2’ fusion protein and performed enzyme-
linked immunosorbent assay (ELISA) to compare the in vitro binding capacity of 
pilV2’ to LPS derived from PAO1+ and PAO1- strains.  
The purified GST-PilV2’ fusion was then tested for binding to various LPSs. As 
shown in Figure 24, the binding capacity of GST-PilV2’ to LPS from PAO1+ was 
significantly decreased, compared to LPS from PAO1-, supporting the idea that the 
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acquisition of PAPI-1 results in the reduction of A-band LPS of PAO1, which in turn 
causes the loss of interaction with the pilus from donor strains.
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Figure 24. Binding of GST-pilV2’ to various LPS preparations in an enzyme-
linked immunosorbent assay. LPS from Salmonella enterica and sample 
without LPS used as negative control. LPS derived from PAO1 carrying PAPI-1 
showed the loss of binding capacity to GST-pilV2’. Results were presented as 
mean ± SD for three independent experiments. Statistical significance was 
assessed by One-way ANOVA (*** p<0.001; ns: no significance, P>0.05). 
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4.9. Disruption of RLO68 and parE in PA14 partially restores transfer 
efficiency 
 
In plasmid transfer, bacteria have been known that they may perform different 
barriers to exclude extra copies of the conjugative elements. Considering that 
PAPI-1 lacks any identifiable homologues of genes involved in LPS biosynthesis 
and modification (data not shown), the factors associated with the reduced amount 
of A-band LPS are more likely to be located in the core genome of P. aeruginosa. 
However, some other factors controlling LPS biosynthesis or responsible for other 
exclusion mechanisms may still be present in PAPI-1. To test this hypothesis, we 
screened a series of PA14 mutants for PAPI-1 genes for their eventual ability to 
restore the acquisition of PAPI-1. Two of ninety-five PA14 mutants for PAPI-1 
genes, PA14_59490 (RL068) and PA14_60050 (parE), were shown possibility to 
receive additional copies of PAPI-1 after mated to PA14TnC2::TcR (Figure 25). 
Compared to the control, RL068 and parE mutants were able to restore 16.6% and 
55% transfer efficiency. The result will be further discussed in the discussion 
section. 
 
 
 
 
91 
 
 
 
 
 
 
Figure 25. PAPI-1 transfer efficiency using PA14 mutants for PAPI-1 genes as 
recipient strains. Disruption of RL068 and parE genes partially restores 16.6% 
and 55% of transfer efficiency of PAPI-1 compared to the positive control, 
respectively. Results are shown as mean ± SD for three independent experiments. 
Statistical significance was analyzed by the unpaired t-test (A) (** p<0.01, and *** 
p<0.001). 
 
 
 
92 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
93 
 
5. DISCUSSION 
Conjugation is a complex process which plays an important role in bacterial 
evolution and adaptation. Conjugation is usually started by the contact between 
donors and recipients, which is diverse among species. In Gram-negative bacteria, 
complex transfer systems are mostly encoded by large self-transmissible plasmids 
by using a type IV secretion apparatus to produce a pilus, so-called the mating-pair 
apparatus. This structure generates a junction between the mating bacterial cells, 
forming a pore through which the plasmid DNA and some donor-encoded proteins 
can be transported to the recipient [143]. In particular, for some plasmid groups, 
the pilus has also been shown to determine the specificity of the interaction with 
the recipient cell surface, in particular with LPS and OM proteins [43] [101]. 
Interestingly, pili encoded by IncP and Ti plasmid groups are able to generate 
junctions with a range of cell types, not only Gram-negative bacteria but also 
Gram-positive bacteria, yeast, plant and animal cells [45] [46]. The general 
process seems to be the same but the transfer can be dramatically affected by the 
identity of the donor [144] [47]. The cell-to-cell contact modalities studied in Gram 
positive bacteria are more diverse than those of Gram-negative bacteria [41]. The 
transfer apparatuses encoded by plasmids in the Gram-positive enterococci is only 
switched on in response to an appropriate recipient through production of 
pheromones, usually hydrophobic peptides [33, 34]. The activation results in the 
production of a membrane protein that promotes aggregation of the donors and 
recipients [35]. Another case of pJI101 plasmid in Streptomyces seems to rely on 
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natural bridges between host hyphae, using a single plasmid-encoded transfer 
protein to implement the movement from donor to recipient [145] [146].  
Little is known about the conjugative systems in the ICEs. However, bioinformatic 
analyses suggest that in Gram-negative bacteria, ICE DNA can mostly be 
transferred through systems similar to type IV secretion systems (T4SSs) [40]. 
This system consists of a membrane-spanning secretion channel and often 
includes an extracellular pilus [147]. Whereas nearly all ICEs discovered in Gram-
negative bacteria possess at least one gene homologous to T4SS [40], several 
ICEs encode almost entire transfer systems that are similar to plasmid-encoded 
T4SSs. The proteins mediating conjugation of Vibrio cholerae ICE SXT, have 34–
78% identity with those in IncA–IncC plasmids [148, 149]. The PAPI-1 conjugation 
system of Pseudomonas aeruginosa also showed a close relationship to plasmid 
transfer apparatus. Homologs of nine PAPI-1 proteins encoding for structural and 
assembly components of a thin conjugative pilus were found in plasmid R64, 
except PilD peptidase, responsible for the cleavage of the PilS2 leader peptide, 
located in the chromosome [93].  
It is known that PAPI-1 can be mobilized from the donor to a recipient lacking this 
island through conjugation. A number of plasmid-based conjugative transfer 
systems, exemplified by the F pilus encoded by the F sex factor of E. coli, are 
required for the initiation of cell-to-cell contact during conjugation and formation of 
mating pairs. Since PAPI-1 conjugation system shares similarity to other 
conjugative plasmids, Herein, we demonstrated that the contact between donor 
and recipient was also established when PAPI-1 is transferred. Our screening on 
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the 32 PAO1 mutants for LPS biosynthesis showed that eleven of them 
significantly reduced the transfer efficiency. Among them, only the PA5001 mutant 
is not clear about its function in LPS biosynthesis, though it was predicted to be 
involved in the core oligosaccharide biosynthesis [106]. The genes algC, wbpZ, 
wbpY, wbpX, wzt, wbpM, gmd, rmd encode enzymes participating in common 
polysaccharide antigen biosynthesis, while the genes PA5455, PA5456, PA5459 
potentially play a role in this pathway [106]. They have been computationally 
predicted to be in 2 operons, except algC which belong to another locus. Our data 
showed that the mutants for those genes significantly decrease the transfer 
efficiency of PAPI-1, compared to control. Noteworthy, the rmd mutant showed a 
slightly higher efficiency compared to negative control which can be explained by 
the cross effect of gmd gene. RMD enzyme (encoded by rmd gene) catalyses the 
final step in the GDP-D-Rha biosynthesis pathway. The disruption of the rmd gene 
on P. aeruginosa chromosome impairs A-band synthesis [133], while in vitro gmd 
is partially capable of catalyzing the same reaction as RMD enzyme [134]. 
Therefore, it could somehow contribute to the A-band biosynthesis in the rmd 
mutant which can help the recipient to receive PAPI-1. Moreover, we also 
observed that the transfer efficiency of the wbpW mutant was comparable to the 
positive control. This is not surprising since it has been recently found that PslB 
gene is able to substitute wbpW gene to promote A-band LPS production in a 
wbpW mutant [150] despite of a low level of this structure [133]. Compared to algC 
mutant, the transfer efficiency of these mutants was a bit higher. As mentioned 
earlier, algC gene is required for the synthesis of a complete LPS core and A-band 
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LPS. Therefore, a complete LPS core would also contribute to the low transfer 
efficiency of algC mutant. However, other mutants such as waaC, waaF and waaP, 
which are involved in core LPS synthesis, did not show a significant decrease in 
PAPI-1 transfer. This would suggest that the A-band is the main LPS structure 
driving the contact and interaction between donor and recipient in P. aeruginosa. 
Moreover, the competition assays with the addition of outer membrane and LPS 
preparations have provided a strong evidence that A-band LPS is involved in the 
recognition of recipient cells in the mating mixture since only LPS preparations 
derived from wbpM and wzx mutants producing only A-band could significantly 
inhibit the transfer of PAPI-1.  
 
Interestingly, LPS structure has also been found as a receptor for conjugative 
transfer and bacteriophages [101] [151]. A detailed study on plasmid R64, the 
most related conjugative system to PAPI-1, showed that LPS core structure, such 
as GlcNAc(α1-2)Glc or Glc(α1-2)Gal structures, plays an important role in 
establishing contact between donor and recipient by specifically binding to PilVB′ 
and PilVC′ adhesins in a liquid medium, respectively [101]. In particular, D-
rhamnose common lipopolysaccharide antigen was also characterized as a 
receptor for A7 bacteriophage. The molecule is hydrolyzed by rhamnanase 
enzymes contained in the phages particles to expose core-lipid A containing only 
two or three rhamnose repeats [152]. This would suggest that the PAPI-1 reception 
might be inherited from bacteriophage transduction in the course of evolution. Our 
findings support the idea that the transfer of PAPI-1 is derived from the plasmid 
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conjugation mechanism in which the conjugative pilus interacts with components of 
the recipient membrane in order to initiate the transfer.  
 
The second main argument in this thesis deals with the behavior of recipients after 
acquisition of PAPI-1 island. ICE acquisition has been shown many benefits for the 
host cell such as the devlopment of resistance to antimicrobial [149],acquisition of 
virulence factors  [153] [154], or establishment of symbiotic association with plants 
[155]. However, transfer of ICEclcB13 has been shown to result in a strong fitness 
cost to the host since it was observed that transfer-competent cells are sacrificed 
after the transfer of ICEs. This could be a consequence of specific high energy 
demand to produce the conjugative system, or excessive oxidative damage; the 
transconjugants might profit from released nutrients from lysed cells [156]. 
Therefore, it is likely that bacteria probably gain profits when they acquire one or 
few ICEs and avoid many others to reduce the fitness costs. In our study, we 
aimed at better understanding how P. aeruginosa behaves after acquisition of 
PAPI-1. We demonstrated that after receiving the PAPI-1 island, the recipients can 
act as stable donors to transfer the island to other recipient cells. This ability is 
well-known for conjugative plasmid transfer (Griffith, 1999) and was recently also 
observed in ICEBs1 from Bacillus subtilis. However, it has not been reported for 
gram-negative bacteria, in particular P. aeruginosa. In this work, we demonstrated 
that the recipient was able to act as a donor for PAPI-1 after it acquired it, with a 
transfer efficiency comparable to that of PA14 strain with original PAPI-1. It still 
remains unclear how much time or generations the recipient needs to act as a 
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donor in P. aeruginosa, though in the B. subtilis cell chains, the recipient can 
rapidly behave as a donor and spread ICEBs1 to the neighboring cells. 
Remarkably, PAPI-1 acquisition was stable after several generations and in fact 
during evolution PAPI-1 is partially or entirely retained in some clinical isolates 
[89]. This would suggest that the acquisition of PAPI-1 would probably benefit to 
the host though it is not well understood in which manner. However, since the size 
of PAPI-1 is pretty large, about 100 kb, it is likely to cause inconvenience to the 
cells due to metabolic cost and genome expansion. Similarly to conjugative 
plasmid, the recipients may respond to a number of incoming ICEs.  
Herein, we demonstrated that the recipient which already acquired PAPI-1 island 
were able to receive more copies though transfer efficiency was significantly 
decreased. In spite we have not defined how many copies of PAPI-1 the recipient 
might carry and how long it might maintain it, the occurrence of multiple copies of 
PAPI-1 at the attB site as a tandem array was previously reported [92]. The 
pathogenicity islands in P.aeruginosa, PAPI-1 and PAPI-2, are known to be 
inserted and excised at the specific att sites located in the two tRNALys genes, 
which were identified as “hot spots” for insertion and excision of large genetic 
elements in several P. aeruginosa strains [92]. For instance, the large plasmid 
pKLK106 in P. aeruginosa clone K was able to recombine sequentially with either 
of the two tRNALys genes PA4541.1 and PA0976.1 to rearrange the genomes of 
sequential K isolates from the airway of a CF patient [157]. In P. aeruginosa clone 
C, the plasmid pKLC102 reversibly integrated only into PA4541.1 but not into 
PA0976.1, which was occupied by a 23-kb PAGI-4 island [94]. In Vibrio cholerae, it 
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was reported that tandem arrays of SXT and R391 elements occurred after their 
transfer, and this arrangement was observed to be stably maintained for many 
generations [58]. These suggested that the attB site in a recipient’s genome can 
be used as a platform to build composite GIs by sequentially acquired independent 
genetic elements to form a superintegron [158]. Finally, the integration of PAPI-1 
into the site for PAPI-2 means that this attB site is conserved and remains intact at 
the borders of the composite element. This feature could be used for acquiring 
multiple ICEs in P. aeruginosa. Harboring at least two ‘’hot spots’’ for integration of 
genetic elements, this bacterium is likely to employ an exclusion system to avoid 
the expansion of its genome and metabolism. This activity has been well 
documented for conjugative plasmids, but there is not much evidence of this for 
ICEs. After acquiring a genetic element, the bacteria can modify their cell surfaces 
or express specific factors to ignore or cleave incoming elements, which are 
classified in different barrier levels. The bacteria might possess and activate one or 
some of them to maintain a stable state, and this would affect the efficiency of the 
transfer after acquiring these elements. In this study, the exclusion activity of PA14 
and PAO1 with PAPI-1 were successfully addressed. Exclusion Index (EI) was 
calculated as the transfer efficiency of PAPI-1 to the recipient lacking this element 
divided by that to a recipient already carrying the same element [56]. The EI for 
mating between PA14 donor and PA14+ recipient was 12, while the EI for mating 
between PAO1+ donor and PAO1+ recipient was about 298, indicating that the 
exclusion activity of PAO1 is stronger than PA14. The observed EI were 
comparable with those of the SXT family of ICEs [66] but about two times lower 
100 
 
than that of virulence plasmid pVAPA1037 [159], six times lower than that of 
plasmid R27-mediated entry exclusion [160] and twenty times lower than exclusion 
mediated by highly promiscuous plasmid RP4, where the EI ranged from 103 to 104  
[52]. This suggested that the exclusion activity for ICEs are less stringent than that 
for conjugative plasmids. In this study, we provided strong evidence that the 
recipient PAO1+ reduced transfer efficiency by three order of magnitudes 
compared to PAO1-. This implies that the PAO1+ can activate a system for 
excluding the acquisition of additional copies of PAPI-1. The exclusion activity is 
well documented for plasmid transfer; but not for ICEs systems, though the 
underlying mechanism seems to be very diverse among bacteria and ICE types. 
Some mechanisms for inhibiting redundant ICE transfer have been reported. For 
example, in the SXT/R391 ICE family, the entry exclusion is mediated by the 
interaction between the Eex inner membrane protein with the TraG protein, a 
component of the mating pore [161, 162]. For the pSAM2 ICE, when it is present in 
the recipient cells, Pif (pSAM2 immunity factor) is expressed to abolish the 
additional transfer from the donor; in consequence, the transfer rate was 2000 
decreased times [59]. A third example deals with an ImmR repressor encoded by a 
recipient bacterium to reduce the integration efficiency of an incoming ICEBs1 by 
1000-fold [163]. However, some other ICEs do not prevent redundant conjugative 
transfer. The presence of Tn916 ICE family in a recipient cell showed a low 
integration specificity, but does not impede transfer of a related element [164]. 
These mechanisms have been grouped as an entry exclusion. In this study, we 
demonstrated that the presence of PAPI-1 in the recipient may detract the 
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interaction between the donor pilus and recipient’s receptor by inhibiting A-band 
LPS biosynthesis. This result was also confirmed by the demonstration of the loss 
of in vitro binding capacity of the pilus tip PilV2’ and LPS preparations and in vivo 
transfer inhibition assays. Noticeably, both LPS preparations from PA14 and 
PA14- did not show any altering effects on transfer efficiency, whereas OM extract 
of PA14– partially inhibited conjugation. This would suggest that A-band LPS of 
PA14 may not be involved in PAPI-1 exclusion activity. Not surprisingly, the PA14 
strain which originally carries PAPI-1 was recently found lacking A-band LPS 
structure [165]. In addition, PA14 and PAO1 genomes (6.5 and 6.3 Mb 
respectively) are remarkably similar, except for differences on their genomic 
islands [166]. One might speculate that during the bacterial evolution, PA14 could 
have evolved from PAO1 after acquiring PAPI-1 from other strains. The different 
behaviors of PA14 and PAO1 strains suggested that more than one exclusion 
mechanisms could be activated in response to the presence of PAPI-1. As 
mentioned earlier, PAPI-1 island belongs to proteobacterial ICEs, such as 
pKLC102 and ICEHin1056, which were described as plasmids and can be present 
as multiple circular copies per cell [157] [167]. Recently, the maintenance of this 
ICE family was also found to be ensured by theta-replication, similar to TnGBS1 
and TnGBS2 from the firmicute S. agalactiae [92, 168, 169]. Therefore, once 
additional PAPI-1 copies succeed to enter into the recipient cell, they may activate 
exclusion mechanisms to avoid the extensive integration of the element. 
Restriction enzymes [170] or clustered regularly interspaced short palindromic 
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repeats (CRISPR) systems [171, 172] are common used by the recipient to 
recognize and cleave incoming ICEs.  
The deletion of two PAPI-1 genes (RL068 and parE) was found here to partially 
restore PAPI-1 transfer efficiency. According to the Pseudomonas database, 
RL068 is a short hypothetical protein, a 91-aa peptide, which does not show any 
conserved domains [128]. Whereas, the parE is a 13.2 kDa protein, belonging to 
the plasmid stabilization protein family. Its sequence shows about 30%-45% 
identity with parE protein encoded in broad-host-range plasmid RK2, and with 
plasmid stabilization protein in Agrobacterium tumefaciens, respectively (data not 
shown). It is also highly conserved among Pseudomonas species. In plasmid RK2 
system, parE was identified as toxic for cell growth by inactivating DNA gyrase; 
however, this activity is prevented by anti-toxin parD protein by forming a complex 
with the parE toxin protein to protect the bacterial cell [173]. This finding supports 
the hypothesis that the presence of PAPI-1 might activate the parE gene to avoid 
its replication and integration into the bacteria chromosome.  
In summary, these results suggest that the P. aeruginosa would activate a 
complex exclusion system after PAPI-1 is acquired. It would include both surface 
exclusion by reducing the amount of A-band LPS and entry exclusion by inhibiting 
the replication and integration of PAPI-1. However, there was no factors encoded 
in PAPI-1 found to be responsible for the reduction of A-band LPS production. It 
remains interesting to study about any factors in the core genome which are 
involved in this exclusion activity. 
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6. CONCLUSION AND PERSPECTIVES 
In this thesis work, we demonstrated for the first time that the horizontal transfer of 
PAPI-1 island is mediated by the interaction between conjugative type IVb pilus of 
the donor cell and A-band LPS on the recipient cell membrane. PAO1 mutants not 
producing A-band LPS showed a significantly decreased efficiency in acquiring the 
island. This statement was confirmed by experiments investigating the effects of 
the addition of outer membrane and LPS preparations from various strains in a 
competitive transfer assay. In the second part of the project, we provided evidence 
for an exclusion mechanism allowing P. aeruginosa to restrict the acquisition and 
integration of additional copies of PAPI-1. Our data suggests that even among P. 
aeruginosa strains PAO1 and PA14 different barriers for PAPI-1 reception may 
occur. We showed that the modified recipient strain PAO1 carrying PAPI-1 
reduces the production of A-band LPS as a probable surface exclusion 
mechanism, by decreasing the binding capacity to the conjugative pilus tip (pilin 
protein pilV2). On the other hand, we showed that strain PA14, that naturally 
carries PAPI-1 island in its genome, tends to exclude the acquisition of extra 
copies. The putative role of PA14 LPS in this exclusion mechanism has still to be 
demonstrated. We demonstrated that the disruption of two genes located in PAPI-
1 partially restore PAPI-1 transfer efficiency although their function has not been 
experimentally demonstrated to date. While PA14_59490 gene has not been 
assigned any function, PA14_60050 encoded for parE functionally predicted as a 
DNA stabilization protein, which may play a role in inhibiting processing and 
integration of further copies of the island. 
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As perspectives, it can be noted that the detailed molecular basis of PAPI-1 
exclusion mechanism has still to be elucidated. A transcriptome analysis of strains 
with or without PAPI-1 should provide important information about regulatory 
aspects of this process. Moreover, a genome-wide screening for factors involving 
in LPS biosynthesis would also help a better understanding on how P. aeruginosa 
controls the transfer and exclusion of PAPI-1. Taken altogether, such approaches 
should assist to get a more complete insight on the horizontal acquisition and 
exclusion of genomic islands, which may result in future development of new 
strategies to limit the spread of virulence or resistance functions in P. aeruginosa 
populations, and potentially in other pathogenic bacteria. 
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ABSTRACT 
 
Pseudomonas aeruginosa pathogenicity island 1 (PAPI-1) is one of the largest 
genomic islands of this important opportunistic human pathogen. Previous studies 
have shown that PAPI-1 encodes several putative virulence factors, a major 
regulator of biofilm formation, antibiotic-resistance traits, and that it is horizontally 
transferable into recipient strains lacking this island. PAPI-1 island is transferred by 
conjugation mediated by specialized type IV pili encoded by a cluster of ten genes 
located in PAPI-1. However, the PAPI-1 acquisition mechanism is currently not 
well understood. In this study, we performed a series of conjugation experiments 
and identified determinants of PAPI-1 acquisition by analyzing transfer efficiency 
between the donor and a series of mutant recipient strains. Our data shows that A-
band lipopolysaccharide (LPS) is required to initiate PAPI-1 transfer, supporting 
the idea that this structure acts as a receptor for conjugative type IV pilus in 
recipient strains. These results were verified by PAPI-1 transfer assay experiments 
supplemented with outer membrane or LPS preparations, and by the binding of 
pilin fusion protein GST-pilV2’ to immobilized LPS molecules in vitro. We also 
demonstrated that P. aeruginosa strains that already acquired a copy of PAPI-1 
almost completely loss the ability to import additional copies of the island, and that 
such strains produced much less A-band LPS compared to the strains lacking 
PAPI-1. This may specify a PAPI-1 exclusion mechanism in P. aeruginosa to avoid 
uncontrolled expansion of the bacterial genome.  
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IMPORTANCE 
 
Horizontal gene transfer (HGT) represents a major evolutionary mechanism for the 
acquisition of new phenotypes by microorganisms. HGT allows rapid evolution on 
a large scale, since hundreds of new genes can be acquired during a single 
genetic exchange event. HGT plays a particularly important role in the evolution of 
virulence and antibiotic resistance as it allows acquisition of genes that can alter 
the pathogenic potential of a bacterial strain.  
The significance of this work is in our ability to experimentally test the molecular 
mechanism of acquisition of genomic islands by HGT. This is not possible in the 
majority of cases as the mobility of these elements is frequently lost because of 
evolutionary decay. New insights about PAPI-1 mobility and its dissemination by 
HGT could be applicable to other systems where experimental validation of 
transmission models is not possible. To our knowledge, this mechanism has never 
been investigated in P. aeruginosa. 
 
 
 
 
 
 
 
 
127 
 
INTRODUCTION 
Horizontal gene transfer (HGT) mediated by microorganisms is a major 
evolutionary mechanism for the acquisition of new functionalities. HGT allows rapid 
and drastic changes in bacterial genomes, since many, even hundreds of new 
genes can be acquired during a single genetic exchange event, and is recognized 
to play an important role in the evolution of virulence, antibiotic resistance and 
adaptation to the new environments (1), (2). The acquisition of virulence genes 
may radically alter the disease-causing potential of a microorganism. In some 
instances, acquisition of a single gene or a small cluster of genes encoding critical 
virulence determinants may be the only genetic difference between an avirulent 
and virulent strain of the same species (3), (4). Virulence genes are often part of 
large blocks of DNA referred to as genomic islands (GIs). GIs are accessory 
genomic segments present only in certain bacterial strains; they are often flanked 
by direct repeats and inserted in the vicinity of tRNA genes.  Reversible excision 
and integration further implicate their potential for inter-bacterial transfer (5) Those 
genomic islands that lead to an enhancement of fitness in a host organism are 
called pathogenicity islands (6). Conjugative and integrative elements (ICEs), or 
conjugative transposons, are well-characterized genomic islands that in many 
cases have retained mobility (7, 8). In contrast, a number of genomic islands 
appear to be ancient ICEs that became fixed in the bacterial chromosome due to 
degeneration of their conjugative elements by deletion of integration sites or 
mutations in genes encoding transfer functions (9). The best-characterized ICEs to 
date contain specific features associated with conjugative plasmids and 
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bacteriophages; can be transferred horizontally following recognition of the 
recipient cell by the donor utilizing a conjugative mechanism that, in many 
instances, is associated to the type IV protein secretion pathway (10). The 
recipient cell is recognized by the pilus structure that is part of the type IV secretion 
apparatus of the donor (11).  
Pseudomonas aeruginosa has a broad environmental distribution that is reflected 
by its large genomic repertoire. Indeed, the genome sequences of P. aeruginosa 
strains available to date show that a large core genome of about 5000 conserved 
genes is supplemented with an accessory gene pool of 1000-1500 additional 
genes, most of them being arranged in a limited number of genomic islands (12). 
PAPI-1 is one of the largest island characterized in P. aeruginosa PA14 (13) a 
highly virulent strain which can infect a broad range of plants, insects, and animals. 
It is integrated at the attB site, located in tRNA-lys genes (14) and consists of a 
cluster of 108 genes that encode a number of virulence determinants, whose 
disruption resulted in the attenuation of the virulence phenotype in several infection 
models (13). In addition, PAPI-1 carries several regulatory genes, such as the 
PvrSR/RcsCB two components system, which controls biofilm formation and 
dispersal in P. aeruginosa strains causing chronic infections in individuals with 
cystic fibrosis [15]. PAPI-1 island is naturally presented in wild-type PA14 strain 
whereas it is missing in PAO1, but it can easily be transferred from PA14 to PAO1. 
PAPI-1 transfer has previously been described as a conjugation process mediated 
by type IVb pilus in co-culture experiments with donor and recipient cells (14, 15). 
Type IVb pilus is encoded by a 10-gene cluster in PAPI-1 (15) and is closely 
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related to the genes found in the enterobacterial plasmid R64. Previous studies on 
conjugal plasmid R64 suggested that the thin pilus PilV adhesins, formed by a 
recombinant mechanism between various cassettes, a shufflon (16) recognize a 
specific structure of the lipopolysaccharide molecules of recipient cells, therefore 
determining the transfer specificity of the plasmid R64 (17).  
The aim of this study was to investigate the mechanism of acquisition of PAPI-1 
island in P. aeruginosa. We performed a series of conjugation experiments on 
wild-type or mutant donor and recipient strains, and analyzed the determinants of 
PAPI-1 transfer efficiency. We demonstrated for the first time that the conjugative 
type IVb pilus of the donor can recognize A-band LPS on the recipient outer 
membrane, and that this structure is required to initiate the transfer of PAPI-1. Our 
data also indicates that P. aeruginosa strains containing PAPI-1 specify a 
mechanism to exclude additional copies of PAPI-1 by producing less A-band LPS.  
RESULTS 
PAO1 mutants for A-band LPS biosynthesis are deficient in the acquisition of 
PAPI-1  
Since in plasmid conjugal transfer the donor pilus is known to recognize specific 
components of LPS on the recipient membrane (18), we decided to examine the 
impact on transfer efficiency by using various mutants for LPS biosynthesis as 
recipients in PAPI-1 transfer assay (Figure 1). The gene AlgC encodes for a 
phosphoglucomutase, which is required for the synthesis of a complete LPS 
structure (19). The mutant PAO1∆algC thus produces a truncated LPS core and is 
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devoid of O-antigen. When the transfer assay was carried out between the donor 
PA14∆TnC2 and PAO1∆algC, the transfer efficiency was reduced by three orders 
of magnitude compared to that of wild-type PAO1 (Figure 1A). This suggests that 
the complete LPS structure plays an important role in PAPI-1 transfer. We 
therefore decided to screen a series of 32 PAO1 mutants for LPS biosynthesis 
(20), using them as recipients in the PAPI-1 transfer assay. The results showed 
that 10 mutants were deficient in PAPI-1 transfer (Figure 1B). Interestingly, these 
mutated genes are located in 2 operons encoding enzymes involved in D-
Rhamnose biosynthesis pathway. This would suggest that the D-rhamnose 
homopolymer, also known as A-band polysaccharide, may act as a receptor for 
conjugative type IV pilus as an initial step of PAPI-1 transfer.  
Addition of OM and A-band LPS preparations inhibits PAPI-1 transfer  
We postulated that OM fractions or A-band LPS preparations, the putative receptor 
for conjugative pilus, can compete with recipient cells binding to the conjugative 
pilus and thus blocking the transfer of PAPI-1 to the recipient. We extracted OM 
and LPS from two PAO1 mutants producing only A-band LPS and two mutants 
producing only B-band LPS (Figure 2). These preparations were added to the 
standard PAPI-1 transfer assay at different concentrations. The increased addition 
of OM and LPS amount from mutants lacking B-band LPS (PAO1∆wbpM and 
PAO1∆wzx) strongly inhibited transfer efficiency, while the addition of OM and LPS 
from mutants lacking A-band LPS (PAO1∆rmd and PAO1∆algC) did not 
significantly affect the efficiency of PAPI-1 transfer. The addition of OM and LPS 
from PAO1∆wbpM and PAO1∆wzx strongly inhibited transfer even at low 
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concentrations (< 5 µg) and reduced transfer efficiency to 20%. These results 
strongly support the hypothesis that A-band LPS of the recipient strain acts as a 
specific receptor for the IVb pilus, and is required to initiate the transfer of PAPI-1. 
Recipient strains carrying PAPI-1 show a strongly reduced ability to acquire 
additional copies of the island  
We then asked if the P. aeruginosa strains already carrying PAPI-1 can acquire 
additional copies of this island. In this experiment, we carried out transfer assays 
using the donor PA14∆TnC2 or PAO1Bla6TnC2 and the recipients with PAPI-1 
(PA14∆TnC2 or PAO1Bla6TnC2) or without PAPI-1 (PA14∆sojR and PAO1). 
Herein, we indicate [+] or [-] for strains with or without PAPI-1, respectively. As 
shown in Figure 3, the transfer efficiency of PA14+ to PA14- is significant lower 
than the control PAO1-. This would suggest that the transfer efficiency of PAPI-1 
may be also influenced by the identity of the recipient strain. Interestingly, the data 
shows that PAO1 strain carrying PAPI-1 can act as a donor of the island, 
transferring it to the control recipient (PAO1-) at an efficiency comparable to the 
PA14+ donor. These results also demonstrate the ability of recipient strains to 
acquire more than one copy of PAPI-1, even if this occurs at much lower efficiency 
compared to controls, with a decrease of one and three orders of magnitude and 
three orders of magnitude for PA14+ to PA14+ and PAO1+ to PAO1+ transfers, 
respectively. Our data thus indicates that P. aeruginosa which already acquired 
PAPI-1 strongly and significantly decreased their ability to receive additional copies 
of the island. This implies that P. aeruginosa strains carrying PAPI-1 specify a 
mechanism to exclude the acquisition of additional copies of the island.  
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The acquisition of PAPI-1 activates a surface exclusion mechanism 
We hypothesized that after acquisition of PAPI-1, recipient P. aeruginosa strains 
modify their surface to avoid further contact and subsequent transfer from the 
donor cells. To infer if the presence of PAPI-1 in the cell genome can affect the 
structure of its OM and LPS, we performed the standard transfer assay with the 
addition of OM and LPS, prepared from strains with and without PAPI-1. As shown 
in Figure 4, the addition of OM preparations derived from strains with PAPI-1 does 
not impact on transfer efficiency, compared to the ones with OM of the strains 
without the island. The effect of LPS preparations (Figure 4B) is similar for PAO1 
strain but not for PA14, since the addition of LPS from PA14- did not produce 
significant variation in transfer efficiency. This data suggests that P. aeruginosa 
specify mechanisms to exclude the acquisition of additional copies of PAPI-1 via 
OM and/or LPS modification. However, the mechanism seems to be different for 
PAO1 and PA14.  
Reduction of A-band LPS production plays a role in the surface exclusion 
mechanism of PAPI-1 
In order to better understand the putative mechanism utilized by P. aeruginosa to 
exclude additional copies of PAPI-1 we first codiered potential alterations in 
surface exclusion. We therefore asked whether the strains containing PAPI-1 could 
modify their LPS structure, which would result in the reduction of the donor’s pilus 
to bind to its receptor. With silver staining of LPS fractionated by SDS-PAGE, no 
differences between the amount of this molecule in a given strain with or without 
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PAPI-1 could be observed (Figure 5A). We then subjected gels to Western blotting 
using a combination of antibodies: MF15-4 (21, 22); N1F10 (21, 23); 5c7-4 (21, 
24); 5c101 (21, 24) recognizing different parts of LPS from PAO1+ and PAO1-. 
This could not be done for PA14 strains because the corresponding antibodies are 
not available. We observed that there were no differences between different part of 
LPS, with the notable exception of the A-band component, showing that PAO1+ 
produces significantly lower amount of A-band LPS compared to PAO1- (Figure 
5B). An possible explanation for this is that after acquiring PAPI-1 island, PAO1 
represses the expression of genes involved in the biosynthesis of A-band LPS, 
leading to a reduced ability to bind the conjugative pilus and thus to act as a 
recipient for PAPI-1 transfer. To confirm that PAO1+ strain lost the recognition of 
donor’s conjugative pilus, we over-expressed and purified a GST-pilV2’ fusion 
protein and performed enzyme-linked immunosorbent assay (ELISA) to compare 
the in vitro binding capacity of pilV2’ to LPS derived from PAO1+ and PAO1- 
strains. PilV2’ is a small pillin protein constituting the type IVb pilus (15) showing 
significant similarity to adhesins PilVB and PilVA’ of plasmid R64, with 40 % of 
identity (data not shown). C-terminal variable segments of R64 pilV adhesins were 
previously shown to interact with LPS of recipient in vitro (17). Therefore, we 
engineered a glutathione transferase (GST) fusion protein carrying at its C-
terminus a 97 amino acid C-terminal segment of PilV2, so-called GST-pilV2’ 
fusion, analogous to the construct used to analyze the R64 pilin interactions with 
its receptor. This GST-PilV2’ fusion was then tested for binding to various LPS 
preparations. As shown in Figure 6, the binding capacity of GST-PilV2’ to LPS 
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from PAO1+ was significantly decreased compare to LPS from PAO1-, supporting 
the idea that the acquisition of PAPI-1 results in the modification of PAO1 LPS, 
which in turn causes the loss of interaction with the pilus from donor strains. 
DISCUSSION 
It is known that horizontal gene transfer plays an important role in driving the 
bacterial evolution and adaptation to various environments. Pseudomonas 
aeruginosa genome has a mosaic structure composed of a variable number of 
horizontally-acquired accessory regions containing up to hundreds of genes (12). 
The largest genomic island in Pseudomonas aeruginosa, PAPI-1, was previously 
shown to be transferable to recipients lacking it through direct cell-to-cell 
interaction and by a conjugation mechanism (15). 
Here, we demonstrate, for the first time, that during conjugation and transfer of 
PAPI-1, the conjugative pilus of the donor recognizes a specific structure, A-band 
LPS, on the recipient membrane. The R64 plasmid transfer also requires the 
recognition by the pilus of specific parts of LPS core. Specifically, the GlcNAc(α1-
2)Glc or Glc(α1-2)Gal structures, are recognized by PilVB′ and PilVC′ adhesins, 
respectively (18). Moreover, LPS molecules have been also found as receptors for 
many bacteriophages (25). In bacteriophage A7, D-rhamnose common 
lipopolysaccharide antigen was also characterized as a receptor which is 
hydrolyzed to expose core-lipid A containing only two or three rhamnose repeats 
by rhamnanase from the phages (26). Our data strongly suggests that the 
conjugative pilus interacts with A-band LPS on the surface of the recipients in 
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order to initiate the transfer of PAPI-1. We also demonstrated that following 
acquisition of the PAPI-1 island, the recipients can become stable donors for 
transfer of the island to other recipient cells. On the other hand, the recipients 
which already acquired PAPI-1 island specify an exclusion mechanism precluding 
the acquisition of additional copies. In conjugal plasmid transfer, a number of 
studies have shown that after acquired plasmids, the recipient bacteria prevent 
entry of additional plasmid copies (27). Exclusion index (EI), which was calculated 
as the transfer efficiency of PAPI-1 to the recipient lacking this element divided by 
that to a recipient already carrying the same element has been used to evaluate 
the exclusion activity (27). The EI for mating between PA14 donor and PA14+ 
recipient was 12, while the EI for mating between PAO1+ donor and PAO1+ 
recipient was about 298, indicating that the exclusion activity of PAO1 is stronger 
than PA14. The observed EI were comparable with those of the SXT family of 
ICEs (28) but about two times lower than virulence plasmid pVAPA1037 (29), six 
times lower than plasmid R27-mediated entry exclusion (30), and twenty times 
lower than exclusion mediated by highly promiscuous plasmid RP4, where the EI 
ranged from 103 to 104 (31). 
At least two exclusion mechanisms for plasmid or ICEs acquisition are known. One 
is entry exclusion (Eex) mediated by inner membrane proteins. This mechanism is 
able to inhibit DNA entry after a stable mating pair has been established (28, 31, 
32). Another mechanism occurs via surface exclusion, inhibiting formation of a 
stable mating pair. TraT, encoded by the F plasmid, is an outer membrane 
lipoprotein which can disturb the interaction between the pilus tip and OmpA 
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receptor in E. coli (32-34). In this study, we provide evidence for another surface-
associated mechanism that Pseudomonas aeruginosa utilizes for excluding 
acquisition of multiple copies of the PAPI-1 island. Preliminary data supporting this 
mechanism is that the strains carrying PAPI-1 produce reduced amounts of the A-
band LPS compared to strains lacking the island and this presumably adversely 
effects the efficiency of the contact between donor and recipient cells.  
The molecular basis of PAPI-1 exclusion mechanism has still to be elucidated. 
Considering that PAPI-1 lacks any identifiable homologues of genes involved in 
LPS biosynthesis and modification (data not shown), the factors causing a 
reduction in the amount of A-band LPS may be conceivably located in the core 
genome of P. aeruginosa. PAPI-1 could therefore specify regulatory functions 
controlling the expression of the enzymes for LPS biosynthesis. We are currently 
screening a series of PA14 mutants for PAPI-1 genes for their eventual ability to 
restore the acquisition of PAPI-1. Our study provides new insights on the 
horizontal acquisition and exclusion of genomic islands which may lead in the 
future development of new strategies to limit the spread of virulence or resistance 
functions in P. aeruginosa populations. 
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MATERIALS AND METHODS 
Strains, plasmids, and culture conditions 
All strains and plasmids used in this study are listed in supplementary table S1. P. 
aeruginosa strains and mutants were grown in Luria-Bertani (LB) broth (Sigma-
Aldrich) supplemented with the appropriate antibiotics. For selection of P. 
aeruginosa mutants, the antibiotics used were gentamicin and tetracycline, both at 
a concentration of 75 µg/ml. For maintenance of plasmids in Escherichia coli, the 
medium was supplemented with ampicillin at 100 µg/ml and chloramphenicol at 34 
µg/ml. Isopropyl-D-thiopyranoside (IPTG) was added at a final concentration of 0.5 
mM to induce GST-pilV2’ expression in pGEX-2T plasmid. 
Construction of PA14∆TnC2::TcR mutant 
The deletion mutant was constructed by using gene replacement vectors as 
previously described (35). All primers used for generating the mutant 
PA14∆TnC2::TcR are listed in supplementary table S3. Briefly, a cassette 
conferring Tet resistance ﬂanked by two DNA fragments of about 500 bp ﬂanking 
the PA14_59200 gene was cloned in the vector pJET1.2 before subcloning into the 
vector pEXG2. The recombinant plasmid was conjugated from E. coli pir S17.1 
into P. aeruginosa (36). The integrative plasmids were selected on LB plates 
supplemented with gentamicin, tetracycline or irgasan at 25 μg/ml. To resolve 
merodiploids a second selection round on LB agar with 6% sucrose was 
performed. Transformants were screened by colony PCR and confirmed by DNA 
sequencing. 
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Screening for PAO1 mutants deficient in PAPI-1 acquisition 
A standard PAPI-1 transfer assay via liquid mating was carried out as previously 
described (15). Mutant PA14∆TnC2 (GmR) was used as donor and a series of 
PAO1 mutants, with altered LPS biosynthesis, obtained from a PAO1 transposon 
mutant library were used as recipients (supplementary table S2). After overnight 
growth at 37 oC and 200 rpm, the donor cells were harvested at an OD 600 of 0.8 
and were mixed with the recipient cells at an OD 600 of 0.4, spun down and 
resuspended in 1 ml of fresh LB without antibiotics. The mating mixture was 
incubated in 15-ml culture tubes, statically at 37 °C for 24 h. The mating mixture 
was diluted to appropriate dilutions and plated on LB agar plates containing 
gentamicin and tetracycline at 75 µg/ml to select transconjugants, and on LB agar 
plates containing tetracycline at 75 µg/ml to select recipients. The transfer 
efficiency was calculated as the ratio of transconjugants and recipients colonies in 
the mating mixture. 
Outer membrane (OM) preparation  
The outer membranes of P. aeruginosa were isolated by using sodium 
lauroylsarkosinate (sarkosyl) as previously described (37). Briefly, cultures of P. 
aeruginosa were grown overnight at 37 °C, 200 rpm in LB broth. The pre-inoculum 
was then diluted 100-fold in fresh LB medium and grown at 37 °C and 200 rpm to 
an OD 600 of 1.0. Cells were harvested and resuspended in 15 ml lysis buffer 
containing 20 mM Tris-Cl [pH 7.5], 100 mM NaCl, 1 mM EDTA, lysozyme [0.5 
mg/ml] and a complete protease inhibitor cocktail (Roche). The lysate was 
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sonicated and spun down at 10,000 g, 10 min, 4 °C to remove cellular debris. The 
membrane fraction was isolated by ultracentrifugation (200,000 g at 4 °C for 60 
min). The pellets containing inner and outer membranes were further fractionated 
at 100,000 g for 30 min after incubation with sarkosyl 0.2 %. Outer membranes 
were finally resuspended in Tris-Cl buffer 20 mM [pH 7.5] and separated on 12% 
sodium dodecyl sulfate (SDS)-polyacrylamide gels and stained with Coomassie 
blue. The concentration of OM was measured by Lowry method. 
 
LPS preparation 
LPS molecules from various P. aeruginosa strains and mutants were prepared by 
using the hot phenol-water extraction protocol from Westphal and Jann (1965) with 
minor modifications (38). Briefly, cell suspensions in 100 mM NaCl were first 
heated to 68 oC before adding an equal volume of hot phenol and stirring 
vigorously for 2 hours at 68 °C. LPS was then fractionated by centrifugation at 
12,000 g for 15 min at 4 °C. LPS in the upper phase was recovered and dialyzed 
against water to remove residual phenol. LPS extract was further treated with 
DNase, RNase and proteinase K to eliminate contaminations. LPS extract was 
finally lyophilized before use. The LPS samples were separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by silver staining 
(39). LPS was then quantified with KDO assay (40). 
PAPI-1 transfer inhibition assay 
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OM and LPS preparations at various concentrations were added to a standard 
mating assay based on plasmid conjugal transfer (41), between the donor 
PA14∆TnC2::GmR and the recipient PAO1::TcR. A mating mixture without the 
addition of OM or LPS was also included as a negative control for this experiment. 
The transfer inhibition index was calculated by dividing the transfer efficiency 
observed with the addition of OM or LPS to that of the control. 
 Western blotting for LPS samples 
LPS samples prepared, by the Hitchcock and Brown method (42), were used for 
western blotting analyses. The western blot protocol for LPS was previously 
explained (38). Briefly, 3 µl of LPS samples was loaded into the 12 % 
discontinuous PAGE gel electrophoresis and run at 200 V for 50 min. LPS was 
electrophoretically transferred onto nitrocellulose membrane at 180 mA for 60 min. 
The membrane was then blocked with 5 % skim milk for 20 min at room 
temperature. The membranes were washed in PBS for 10 min; the primary 
antibodies against to different parts of LPS structure,were added  and  incubation 
continued overnight. Following a 10 min PBS wash, secondary antibodies were 
added for an additional hour. The membrane was washed for 10 min in PBS and 
developed by BCIP/NBT detection kit. 
Expression and purification of GST-pilV2’ fusion protein 
The C-terminal region of pilV2 gene encoding 97 residues was amplified with the 
primers listed in supplementary table S3 and cloned into pJET 1.2/Blunt. The insert 
was then subcloned into the expression vector pGEX-2T (Life Technologies) and 
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transformed into E. coli BL21. E. coli BL21 containing pGEX-2T-pilV2’ was grown 
to an OD of 0.6 at 37oC, at 200 rpm, before adding IPTG to induce expression of 
GST-pilV2’ protein. The culture was incubated for additional 3 hours. The cells 
were collected by centrifugation at 8000 rpm, 4 oC for 20 min. The GST-pilV2’ 
fusion protein was then purified by using glutathione Sepharose 4B (GE 
Healthcare), as previously described (43). 
Microtiter plate binding assay 
Binding of LPS to GST-pilV2’ fusion was quantified by a modified enzyme-linked 
plate assay essentially as previously described (44). Microtiter plates (Corning) 
were coated with 10 μg/ml LPS from PAO1 and PAO1 with PAPI-1 suspended in 
PBS (0.137 M NaCl, 0.005 M KCl, 0.009 M Na2HPO4, and 0.001 M KH2PO4 (pH 
7.4)) containing 0.05% Tween 20 (v/v, PBST). The plates were then washed with 
PBST and blocked with 3% BSA. GST-pilV2’ fusion was added to the wells coated 
with LPS and incubated for 2 h at room temperature. After three washes with 
PBST, mouse anti-GST antibody was added and incubated for 1.5 h following 
three washes with PBST, HRP-labeled anti-mouse Ig (Sigma-Aldrich) was added 
for one hour, follwed by three aditional washes. A solution of 3,3′,5,5′-
tetramethylbenzidine (Thermo Scientific) was used for color development and ODs 
were measured at 450 nm. LPS from Salmonella enterica was used as a negative 
control. 
 
 
142 
 
FUNDING INFORMATION 
This work was supported by AREA1104038 PhD fellowship assigned to THP from 
the European Commission, and by OJ’s startup fund at the Centre for Integrative 
Biology. The funders had no role in study design, data collection and interpretation, 
or on the decision to submit the work for publication. 
 
ACKNOWLEDGMENTS 
We are grateful to Joseph Lam and Youai Hao for their kind contribution in LPS 
analyses (figure 5) and Alessandra Polissi for helping us with LPS preparations.  
 
 
 
 
 
 
 
 
 
143 
 
REFERENCES 
1. Hacker J, Kaper JB. 2000. Pathogenicity islands and the evolution of 
microbes. Annu Rev Microbiol 54:641-679. 
2. Croucher NJ, Walker D, Romero P, Lennard N, Paterson GK, Bason NC, 
Mitchell AM, Quail MA, Andrew PW, Parkhill J, Bentley SD, Mitchell TJ. 2009. Role 
of conjugative elements in the evolution of the multidrug-resistant pandemic clone 
Streptococcus pneumoniaeSpain23F ST81. J Bacteriol 191:1480-1489. 
3. Imamovic L, Tozzoli R, Michelacci V, Minelli F, Marziano ML, Caprioli A, 
Morabito S. 2010. OI-57, a genomic island of Escherichia coli O157, is present in 
other seropathotypes of Shiga toxin-producing E. coli associated with severe 
human disease. Infect Immun 78:4697-4704. 
4. Gartemann KH, Abt B, Bekel T, Burger A, Engemann J, Flugel M, Gaigalat 
L, Goesmann A, Grafen I, Kalinowski J, Kaup O, Kirchner O, Krause L, Linke B, 
McHardy A, Meyer F, Pohle S, Ruckert C, Schneiker S, Zellermann EM, Puhler A, 
Eichenlaub R, Kaiser O, Bartels D. 2008. The genome sequence of the tomato-
pathogenic actinomycete Clavibacter michiganensis subsp. michiganensis 
NCPPB382 reveals a large island involved in pathogenicity. J Bacteriol 190:2138-
2149. 
5. Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H. 1997. Pathogenicity 
islands of virulent bacteria: structure, function and impact on microbial evolution. 
Mol Microbiol 23:1089-1097. 
144 
 
6. Dobrindt U, Hochhut B, Hentschel U, Hacker J. 2004. Genomic islands in 
pathogenic and environmental microorganisms. Nat Rev Microbiol 2:414-424. 
7. Burrus V, Marrero J, Waldor MK. 2006. The current ICE age: biology and 
evolution of SXT-related integrating conjugative elements. Plasmid 55:173-183. 
8. Burrus V, Pavlovic G, Decaris B, Guedon G. 2002. Conjugative 
transposons: the tip of the iceberg. Mol Microbiol 46:601-610. 
9. Kung VL, Ozer EA, Hauser AR. 2010. The accessory genome of 
Pseudomonas aeruginosa. Microbiol Mol Biol Rev 74:621-641. 
10. Burrus V, Waldor MK. 2004. Shaping bacterial genomes with integrative 
and conjugative elements. Res Microbiol 155:376-386. 
11. Lawley TD, Klimke WA, Gubbins MJ, Frost LS. 2003. F factor conjugation is 
a true type IV secretion system. FEMS Microbiol Lett 224:1-15. 
12. Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, Koehrsen M, 
Rokas A, Yandava CN, Engels R, Zeng E, Olavarietta R, Doud M, Smith RS, 
Montgomery P, White JR, Godfrey PA, Kodira C, Birren B, Galagan JE, Lory S. 
2008. Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad 
Sci U S A 105:3100-3105. 
13. He J, Baldini RL, Deziel E, Saucier M, Zhang Q, Liberati NT, Lee D, Urbach 
J, Goodman HM, Rahme LG. 2004. The broad host range pathogen Pseudomonas 
aeruginosa strain PA14 carries two pathogenicity islands harboring plant and 
animal virulence genes. Proc Natl Acad Sci U S A 101:2530-2535. 
145 
 
14. Qiu X, Gurkar AU, Lory S. 2006. Interstrain transfer of the large 
pathogenicity island (PAPI-1) of Pseudomonas aeruginosa. Proc Natl Acad Sci U 
S A 103:19830-19835. 
15. Carter MQ, Chen J, Lory S. 2010. The Pseudomonas aeruginosa 
pathogenicity island PAPI-1 is transferred via a novel type IV pilus. J Bacteriol 
192:3249-3258. 
16. Komano T. 1999. Shufflons: multiple inversion systems and integrons. Annu 
Rev Genet 33:171-191. 
17. Ishiwa A, Komano T. 2004. PilV adhesins of plasmid R64 thin pili 
specifically bind to the lipopolysaccharides of recipient cells. J Mol Biol 343:615-
625. 
18. Ishiwa A, Komano T. 2003. Thin pilus PilV adhesins of plasmid R64 
recognize specific structures of the lipopolysaccharide molecules of recipient cells. 
J Bacteriol 185:5192-5199. 
19. Rocchetta HL, Burrows LL, Lam JS. 1999. Genetics of O-antigen 
biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 63:523-553. 
20. King JD, Kocincova D, Westman EL, Lam JS. 2009. Review: 
Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun 
15:261-312. 
146 
 
21. Forsberg LS, Carlson RW. 1998. The structures of the lipopolysaccharides 
from Rhizobium etli strains CE358 and CE359. The complete structure of the core 
region of R. etli lipopolysaccharides. J Biol Chem 273:2747-2757. 
22. Huszar G, Jenei B, Szabo G, Medgyesi GA. 2002. Detection of pyrogens in 
intravenous IgG preparations. Biologicals 30:77-83. 
23. Ochiai M, Yamamoto A, Kataoka M, Toyoizumi H, Horiuchi Y. 2001. 
Interfering effect of diphtheria-tetanus-acellular pertussis combined (DTaP) 
vaccines on the bacterial endotoxin test. Biologicals 29:55-58. 
24. Bang FB. 1956. A bacterial disease of Limulus polyphemus. Bull Johns 
Hopkins Hosp 98:325-351. 
25. Picken RN, Beacham IR. 1977. Bacteriophage-resistant mutants of 
Escherichia coli K12. Location of receptors within the lipopolysaccharide. J Gen 
Microbiol 102:305-318. 
26. Rivera M, Chivers TR, Lam JS, McGroarty EJ. 1992. Common antigen 
lipopolysaccharide from Pseudomonas aeruginosa AK1401 as a receptor for 
bacteriophage A7. J Bacteriol 174:2407-2411. 
27. Garcillan-Barcia MP, de la Cruz F. 2008. Why is entry exclusion an 
essential feature of conjugative plasmids? Plasmid 60:1-18. 
28. Marrero J, Waldor MK. 2005. Interactions between inner membrane 
proteins in donor and recipient cells limit conjugal DNA transfer. Dev Cell 8:963-
970. 
147 
 
29. Tripathi VN, Harding WC, Willingham-Lane JM, Hondalus MK. 2012. 
Conjugal transfer of a virulence plasmid in the opportunistic intracellular 
actinomycete Rhodococcus equi. J Bacteriol 194:6790-6801. 
30. Gunton JE, Ussher JE, Rooker MM, Wetsch NM, Alonso G, Taylor DE. 
2008. Entry exclusion in the IncHI1 plasmid R27 is mediated by EexA and EexB. 
Plasmid 59:86-101. 
31. Haase J, Kalkum M, Lanka E. 1996. TrbK, a small cytoplasmic membrane 
lipoprotein, functions in entry exclusion of the IncP alpha plasmid RP4. J Bacteriol 
178:6720-6729. 
32. Sukupolvi S, O'Connor CD. 1990. TraT lipoprotein, a plasmid-specified 
mediator of interactions between gram-negative bacteria and their environment. 
Microbiol Rev 54:331-341. 
33. Achtman M, Kennedy N, Skurray R. 1977. Cell--cell interactions in 
conjugating Escherichia coli: role of traT protein in surface exclusion. Proc Natl 
Acad Sci U S A 74:5104-5108. 
34. Riede I, Eschbach ML. 1986. Evidence that TraT interacts with OmpA of 
Escherichia coli. FEBS Lett 205:241-245. 
35. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. 1998. A 
broad-host-range Flp-FRT recombination system for site-specific excision of 
chromosomally-located DNA sequences: application for isolation of unmarked 
Pseudomonas aeruginosa mutants. Gene 212:77-86. 
148 
 
36. Simon R, Priefer U, Pühler A. 1983. A Broad Host Range Mobilization 
System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram 
Negative Bacteria. Bio/Technology 1:784-791. 
37. Ravaoarinoro M, Ciurli C, Toma E, Morisset R. 1994. Rapid method for 
isolating detergent-insoluble outer membrane proteins from Pseudomonas 
aeruginosa. Electrophoresis 15:594-596. 
38. Lam JS, Anderson EM, Hao Y. 2014. LPS quantitation procedures. Methods 
Mol Biol 1149:375-402. 
39. Fomsgaard A, Freudenberg MA, Galanos C. 1990. Modification of the silver 
staining technique to detect lipopolysaccharide in polyacrylamide gels. J Clin 
Microbiol 28:2627-2631. 
40. Lee CH, Tsai CM. 1999. Quantification of bacterial lipopolysaccharides by 
the purpald assay: measuring formaldehyde generated from 2-keto-3-
deoxyoctonate and heptose at the inner core by periodate oxidation. Anal Biochem 
267:161-168. 
41. Genco CA, Clark VL. 1988. Role of outer-membrane proteins and 
lipopolysaccharide in conjugation between Neisseria gonorrhoeae and Neisseria 
cinerea. J Gen Microbiol 134:3285-3294. 
42. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among 
Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J 
Bacteriol 154:269-277. 
149 
 
43. Frangioni JV, Neel BG. 1993. Solubilization and purification of enzymatically 
active glutathione S-transferase (pGEX) fusion proteins. Anal Biochem 210:179-
187. 
44. Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS. 2008. High mobility group box 
1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to 
CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human 
monocytes. J Immunol 180:5067-5074. 
 
 
 
 
 
 
 
 
 
 
 
 
150 
 
FIGURES 
 
Figure 1. PAPI-1 transfer efficiency using PAO1 mutants for LPS 
biosynthesis genes as recipient strains. (A) Transfer efficiency into PAO1algC 
(B) Transfer efficiency into various PAO1 mutants for LPS biosynthesis. Positive 
control (POS): PAO1::TcR and Negative control (NEG): PAO1algC. Results were 
shown as mean ± SD for three independent replicates. Statistical significance was 
calculated by the unpaired t-test (A) and One-way ANOVA compared to the 
positive control (B) (ns: no significant; and *** p < 0.001). 
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Figure 26. Effect on PAPI-1 transfer efficiency of the addition of OM (A) and 
LPS (B) preparations from PAO1 mutants lacking either A-band or B-band 
LPS.  Red, PAO1rmd (A-,B+); green, PAO1algC (A-, B+); blue, PAO1wbpM 
(A+, B-); purple, PAO1wzx (A+,B-). 
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Figure 3. Transfer efficiency of multiple PAPI-1 copies into recipient strains. 
Marks [+] or [-] stand for strains with or without PAPI-1, respectively. After 
acquisition of PAPI-1, PAO1 becomes a stable donor which can transfer PAPI-1 to 
another recipient and decreases its ability of receiving additional copies of PAPI-1. 
Results are presented as mean ± SD for three independent experiments. 
Statistical significance was calculated by the unpaired t-test (A) (** p<0.01, and *** 
p<0.001). 
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Figure 4. Effect on PAPI-1 transfer of the addition of OM (A) and LPS (B) 
preparations derived from strains with (+) or without (-) PAPI-1 island. Pink, 
PAO1-; orange, PAO1+; gray, PA14+; blue, PA14-. Purple data point on (B) are LPS 
from Salmonella enterica used as negative control.  
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Figure 5. Analysis of LPS preparations from PAO1 and PA14 strains with (+) 
or without (-) PAPI-1. (A) LPS silver staining. (B) Western blot with a combination 
of antibodies specifically recognizing A-band (N1F10), B-band (MF15-4), outer 
core (5c101) and inner core (5c7-4). 
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Figure 6. Binding of GST-pilV2’ to various LPS preparations in an enzyme-
linked immunosorbent assay. LPS from Salmonella enterica and sample 
without LPS used as negative control. LPS derived from PAO1 carrying PAPI-1 
showed the loss of binding capacity to GST-pilV2’. Results were presented as 
mean ± SD for three independent experiments. Statistical significance was 
assessed by One-way ANOVA (*** p<0.001; ns: no significance, P>0.05). 
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Table 1. Strains and plasmids used in this study 
Strains or plasmids 
Antibiotic 
resistancea 
Description 
Source 
reference, or 
accession no. 
E. coli strains 
   
E. coli SM10 None 
Host strain for plasmids 
pEXG2, mini-CTX, and their 
derivatives 
Lory’s lab 
collection 
E. coli pir S17.1 None 
Transfer pEXG2 plasmid into 
P. aeruginosa by conjugation 
(1) 
P. aeruginosa strains 
  
PA14 None Burn isolate (2) 
PA14∆soj (PA14 -) GmR 
Deletion mutant of PAPI-
1 soj in strain PA14, which 
does not carry PAPI-1 island 
(2) 
PA14∆TnC2::GmR 
(PA14+) 
GmR 
Strain PA14 with a transposon 
MAR2×T7 inserted at 
nucleotide 1634 of PAPI-1 
gene RL090 (PA14_59200) 
(3)  
PA14∆TnC2::TcR 
(PA14+) 
TcR 
Partially deletion of 
the PA14_59200 gene in 
strain PA14 by insertion of 
tetracycline resistant gene in 
the middle 
This study 
PAO1 (or PAO1 -) TcR 
PAO1 with Tet gene inserted 
at the CTX phage att site on 
the chromosome 
Lory’s lab 
collection 
PAO1Bla6 CbR 
PAO1 with genes bla and 
lacZ inserted at the CTX 
phage att site on the 
chromosome 
(2)  
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PAO1Bla6TnC2::GmR 
(PAO1+) 
GmR 
CbR 
Transconjugant of the mating 
between PA14∆TnC2 (GmR) 
and PAO1Bla6 
This study 
PAO1Bla6TnC2::TcR 
(PAO1+) 
GmR 
CbR 
Transconjugant of the mating 
between PA14∆TnC2::TcR 
and PAO1Bla6 
This study 
Plasmids 
   
pEXG2 GmR 
Gene replacement vector for 
constructing deletion or 
insertion mutants of P. 
aeruginosa 
(4)  
pJET1.2 AmpR 
Plasmid used for DNA blunt 
cloning 
Thermo 
Scientific 
pGEX-2T AmpR 
Expression vector for GST-
pilV2’ 
GE Healthcare 
pJET1.2 AmpR 
Plasmid used for DNA blunt 
cloning 
Thermo 
Scientific 
pGEX-2T AmpR 
Expression vector for GST-
pilV2’ 
GE Healthcare 
 
↵a Ampr, ampicillin resistance; Gmr, gentamicin resistance; Cbr, carbenicillin resistance; 
Tcr, tetracycline resistance. 
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Supplementary table SA1. List of PAO1 mutants for lipopolysaccharide 
biosynthesis 
Number 
PA 
ORF 
Gene 
Abbrev. 
Putative ORF Function 
Position in PAO1 
transposon 
mutant library 
(source:[5]) 
1 PA0705 migA alpha-1,6-rhamnosyltransferase MigA phoAwp01q4A03 
2 PA0936 lpxO2 lipopolysaccharide biosynthetic protein LpxO2 lacZwp03q3H09 
3 PA3141 wbpM nucleotide sugar epimerase/dehydratase  (*) 
4 PA3157   probable acetyltransferase phoAwp08q3G06 
5 PA3160 wzz O-antigen chain length regulator phoAbp02q3G06 
6 PA3193 glk Glucokinase phoAwp07q4C11 
7 PA3337 rfaD ADP-L-glycero-D-mannoheptose 6-epimerase phoAwp05q3A01 
8 PA3552 arnB ArnB phoAwp08q4G12 
9 PA3554 arnA ArnA lacZwp07q3F04 
10 PA3555 arnD ArnD phoAwp04q2C06 
11 PA3556 arnT inner membrane L-Ara4N transferase ArnT lacZwp07q1F11 
12 PA4458   conserved hypothetical protein phoAwp07q2G01 
13 PA4512 lpxO1 lipopolysaccharide biosynthetic protein LpxO1 phoAwp07q3E07 
14 PA4661 pagL Lipid A 3-O-deacylase phoAbp02q4E08 
15 PA5001   hypothetical protein phoAwp01q3H11 
16 PA5002   hypothetical protein lacZbp03q3E06 
17 PA5005   probable carbamoyl transferase phoAwp09q3B06 
18 PA5009 waaP lipopolysaccharide kinase WaaP phoAwp05q4G09 
19 PA5011 waaC heptosyltransferase I lacZwp04q4G06 
20 PA5012 waaF heptosyltransferase II lacZwp08q1C03 
21 PA5447 wbpZ glycosyltransferase WbpZ lacZwp02q1H10 
22 PA5448 wbpY glycosyltransferase WbpY phoAwp02q1F12 
23 PA5449 wbpX glycosyltransferase WbpX lacZwp01q4A02 
24 PA5450 wzt ABC subunit of A-band LPS efflux transporter phoAwp10q1E09 
25 PA5452 wbpW 
phosphomannose isomerase/GDP-mannose 
WbpW lacZwp08q4H11 
26 PA5453 gmd GDP-mannose 4,6-dehydratase lacZwp02q3E02 
27 PA5454 rmd oxidoreductase Rmd lacZwp01q1B08 
28 PA5455   hypothetical protein phoAwp08q4H06 
29 PA5456   hypothetical protein lacZwp02q4C05 
30 PA5457   hypothetical protein lacZwp06q1F08 
31 PA5458   hypothetical protein phoAwp10q1C10 
32 PA5459   hypothetical protein phoAwp08q1B12 
33 PA5322 algC phosphomannomutase phoAwp07q4D07 
 
 (*): Lory’s lab collection 
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Supplementary table SA2. Primers used in this study 
Primer  Sequence (5’-3’) Description Source 
TnC2-US-F GGTACCGGCAACACATTTCTCCCTCG 
Amplify a 
fragment of 532 
bp upstream of 
PA14_59200 
gene 
This 
study 
TnC2-US-R TCTAGATTGAGCCAGCCAGTTGTAGA 
TnC2-DS-F TCTAGACGGCTGAGAGACATCAAGGA 
Amplify a 
fragment of 594 
bp downstream 
of PA14_59200 
gene 
This 
study 
TnC2-DS-R AAGCTTGTTCAGGTTCGTCGCTATGG 
Tc-F TCTAGATCAGGTCGAGGTGGCCC Amplify Tet gene 
from mini-CTX2 
plasmid 
This 
study 
Tc-R TCTAGAAGAGCGCTTTTGAAGCTAATTCGCTG 
TnC2-Li-F CTTGACGAGTTTGCTGCACT Check the insert 
of Tet gene on 
the left junction 
This 
study 
TnC2-Li-R GAGAAGCAGGCCATTATCGC 
TnC2-Ri-F GAACGGGTGCGCATAGAAAT Check the insert 
of Tet gene on 
the right junction 
This 
study 
TnC2-Ri-R TTCGACCAAGGAGCTGAACT 
pilV2-F ATAGGATCCCTGTCCTGCCAAAACGGG Amplify C-
terminal region 
of pilV2 gene 
(97 amino acid) 
This 
study 
pilV2-R ATATGAATTCCTAGTTCACGCAGGTAACGG 
intF AGCTACATCGAGGCCGACTA 
Check the 
insertion of 
PAPI-1 on the 
left junction of 
attL site 
(2) 
4542F GTGGTGATGACCTCCAACCT (2) 
sojR CGAGCACAGAAATGTCCTGA 
Check the 
insertion of 
PAPI-1 on the 
right junction of 
attR site 
(2) 
4541F GACAAGACCAGCCACAACCT 
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